ShaoY_2019_ERR3404634_bin.2_k119_528_2	megares|MEG_6058|Drugs|MLS|23S_rRNA_methyltransferases|RLMH_1	60.4	159	160	159	2.21e-60	183
ShaoY_2019_ERR3404634_bin.2_k119_588_4	SARG|CAB12101	33.6	503	489	512	8.90e-76	246
ShaoY_2019_ERR3404634_bin.2_k119_588_4	SARG|ZP_03053667	36.0	411	489	506	1.73e-73	239
ShaoY_2019_ERR3404634_bin.2_k119_588_4	SARG|YP_001486998	35.8	411	489	530	6.05e-73	239
ShaoY_2019_ERR3404634_bin.2_k119_588_4	SARG|YP_001419960	34.0	406	489	510	1.63e-70	232
ShaoY_2019_ERR3404634_bin.2_k119_588_4	SARG|AAC15775	29.7	435	489	536	1.69e-50	179
ShaoY_2019_ERR3404634_bin.2_k119_588_4	SARG|AAD04032	29.7	435	489	563	2.64e-50	179
ShaoY_2019_ERR3404634_bin.2_k119_588_4	megares|MEG_4380|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|OTRB_1	29.7	435	489	563	2.64e-50	179
ShaoY_2019_ERR3404634_bin.2_k119_588_4	megares|MEG_4381|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|OTRB_1	29.7	435	489	563	2.64e-50	179
ShaoY_2019_ERR3404634_bin.2_k119_588_4	SARG|gb|BAB43261.1|ARO:3007013|sdrM	29.6	405	489	447	1.15e-46	167
ShaoY_2019_ERR3404634_bin.2_k119_588_4	CARD|gb|NP_216393.1|ARO:3007662|Rv1877	29.0	465	489	687	8.63e-45	166
ShaoY_2019_ERR3404634_bin.2_k119_588_7	SARG|gb|AAK76137.1|ARO:3000024|patA	56.2	564	572	564	2.73e-213	603
ShaoY_2019_ERR3404634_bin.2_k119_588_7	SARG|gb|WP_104671188.1|ARO:3003948|efrA	37.1	577	572	575	1.26e-111	343
ShaoY_2019_ERR3404634_bin.2_k119_588_7	SARG|gi|493394434|ref|WP_006350564.1|	29.7	576	572	602	2.76e-61	212
ShaoY_2019_ERR3404634_bin.2_k119_588_7	SARG|gb|CDO61516.1|ARO:3003949|efrB	34.5	345	572	362	8.87e-61	204
ShaoY_2019_ERR3404634_bin.2_k119_588_7	SARG|gi|516574297|ref|WP_017949361.1|	30.3	548	572	620	7.22e-60	208
ShaoY_2019_ERR3404634_bin.2_k119_588_7	SARG|gi|739906046|ref|WP_037756452.1|	30.3	548	572	620	1.39e-59	207
ShaoY_2019_ERR3404634_bin.2_k119_588_7	SARG|gi|953808775|ref|WP_058042812.1|	29.5	590	572	608	5.73e-59	206
ShaoY_2019_ERR3404634_bin.2_k119_588_7	SARG|gi|664244930|ref|WP_030776974.1|	43.0	258	572	601	9.72e-59	205
ShaoY_2019_ERR3404634_bin.2_k119_588_7	SARG|gi|948137056|ref|WP_056795395.1|	43.0	251	572	602	1.37e-58	204
ShaoY_2019_ERR3404634_bin.2_k119_588_7	SARG|gi|664458452|ref|WP_030980047.1|	30.5	544	572	601	1.86e-58	204
ShaoY_2019_ERR3404634_bin.2_k119_588_8	SARG|gb|AYV52072.1|ARO:3002882|lmrD	55.3	655	590	664	6.29e-239	673
ShaoY_2019_ERR3404634_bin.2_k119_588_8	SARG|gb|AAK76136.1|ARO:3000025|patB	57.3	588	590	588	8.98e-235	659
ShaoY_2019_ERR3404634_bin.2_k119_588_8	SARG|gi|497748188|ref|WP_010062372.1|	33.2	509	590	605	4.85e-90	289
ShaoY_2019_ERR3404634_bin.2_k119_588_8	SARG|gi|948137056|ref|WP_056795395.1|	33.6	509	590	602	3.42e-89	286
ShaoY_2019_ERR3404634_bin.2_k119_588_8	SARG|gi|695865802|ref|WP_032778631.1|	32.8	509	590	605	3.68e-89	286
ShaoY_2019_ERR3404634_bin.2_k119_588_8	SARG|gi|648667297|ref|WP_026359044.1|	33.7	513	590	605	7.24e-89	286
ShaoY_2019_ERR3404634_bin.2_k119_588_8	SARG|gi|664180077|ref|WP_030714054.1|	32.8	509	590	605	7.24e-89	286
ShaoY_2019_ERR3404634_bin.2_k119_588_8	SARG|gi|764446018|ref|WP_044369325.1|	33.0	509	590	605	1.01e-88	285
ShaoY_2019_ERR3404634_bin.2_k119_588_8	SARG|gi|695887424|ref|WP_032788534.1|	32.8	509	590	605	2.80e-88	284
ShaoY_2019_ERR3404634_bin.2_k119_588_8	SARG|gi|1045390184|ref|WP_065479071.1|	32.8	509	590	605	2.80e-88	284
ShaoY_2019_ERR3404634_bin.2_k119_588_11	SARG|gb|AAK76137.1|ARO:3000024|patA	24.8	210	223	564	2.22e-11	61.6
ShaoY_2019_ERR3404634_bin.2_k119_588_11	NCBI|AKC61310.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	34.1	85	223	552	4.81e-09	54.7
ShaoY_2019_ERR3404634_bin.2_k119_588_14	SARG|gb|BAG33043.1|ARO:3003920|pgpB	30.6	121	217	236	3.28e-06	45.4
ShaoY_2019_ERR3404634_bin.2_k119_588_14	megares|MEG_5776|Drugs|Lipopeptide|Lipid_A_phosphatase|PGBB_1	30.6	121	217	236	3.28e-06	45.4
ShaoY_2019_ERR3404634_bin.2_k119_588_18	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	22.2	760	805	1033	5.88e-25	110
ShaoY_2019_ERR3404634_bin.2_k119_588_18	SARG|gb|AEY83581|ARO:3000510|mupB	22.2	760	805	1033	5.88e-25	110
ShaoY_2019_ERR3404634_bin.2_k119_588_18	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	21.3	870	805	1024	6.98e-24	107
ShaoY_2019_ERR3404634_bin.2_k119_588_18	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	21.3	870	805	1024	6.98e-24	107
ShaoY_2019_ERR3404634_bin.2_k119_588_18	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	21.3	870	805	1024	6.98e-24	107
ShaoY_2019_ERR3404634_bin.2_k119_588_18	SARG|gb|CAA53189|ARO:3000521|mupA	21.3	870	805	1024	6.98e-24	107
ShaoY_2019_ERR3404634_bin.2_k119_588_22	SARG|gi|498115003|ref|WP_010429159.1|	37.6	194	212	646	4.49e-30	115
ShaoY_2019_ERR3404634_bin.2_k119_588_22	SARG|gi|654551607|ref|WP_028019265.1|	37.1	194	212	646	3.94e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_588_22	SARG|gi|782756348|ref|WP_045630015.1|	37.1	194	212	646	3.94e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_588_22	SARG|gi|895898290|ref|WP_048999361.1|	37.1	194	212	646	3.94e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_588_22	SARG|gi|896106549|ref|WP_049136608.1|	36.7	188	212	646	3.94e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_588_22	SARG|gi|983405167|ref|WP_060572706.1|	37.1	194	212	646	3.94e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_588_22	SARG|gi|779850732|ref|WP_045348329.1|	37.1	194	212	646	3.94e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_588_22	SARG|gi|654544841|ref|WP_028012549.1|	36.7	188	212	646	5.38e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_588_22	SARG|gi|974588181|ref|WP_059178476.1|	36.6	194	212	646	5.38e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_588_22	SARG|gi|765031087|ref|WP_044596899.1|	37.1	194	212	646	5.38e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_744_9	SARG|JQ861959.1.gene5.p01	40.6	286	288	287	1.23e-74	229
ShaoY_2019_ERR3404634_bin.2_k119_744_9	NCBI|WP_001255866.1|1|1|ant(6)-Ia|ant(6)-Ia|nucleotidyltransferase|2|STREPTOMYCIN|aminoglycoside|aminoglycoside_nucleotidyltransferase_ANT(6)-Ia|AMR|aminoglycoside	39.4	282	288	302	1.25e-72	224
ShaoY_2019_ERR3404634_bin.2_k119_744_9	NCBI|WP_001255864.1|1|1|ant(6)-Ia|ant(6)-Ia|nucleotidyltransferase|2|STREPTOMYCIN|aminoglycoside|aminoglycoside_nucleotidyltransferase_ANT(6)-Ia|AMR|aminoglycoside	38.3	282	288	302	1.42e-71	221
ShaoY_2019_ERR3404634_bin.2_k119_744_9	NCBI|WP_032491779.1|1|1|ant(6)-Ia|ant(6)-Ia|nucleotidyltransferase|2|STREPTOMYCIN|aminoglycoside|aminoglycoside_nucleotidyltransferase_ANT(6)-Ia|AMR|aminoglycoside	39.0	282	288	302	1.60e-70	219
ShaoY_2019_ERR3404634_bin.2_k119_744_9	SARG|FN594949.1.gene25.p01	39.8	264	288	285	1.54e-69	216
ShaoY_2019_ERR3404634_bin.2_k119_744_9	SARG|gi|1039476118|ref|WP_064814315.1|	38.2	280	288	284	6.75e-68	211
ShaoY_2019_ERR3404634_bin.2_k119_744_9	SARG|gi|749035552|ref|WP_040082373.1|	38.6	280	288	284	2.70e-67	210
ShaoY_2019_ERR3404634_bin.2_k119_744_9	NCBI|WP_087343787.1|1|1|ant(6)-Ic|ant(6)-Ic|nucleotidyltransferase|2|STREPTOMYCIN|aminoglycoside|aminoglycoside_nucleotidyltransferase_ANT(6)-Ic|AMR|aminoglycoside	38.6	280	288	286	2.87e-67	210
ShaoY_2019_ERR3404634_bin.2_k119_744_9	megares|MEG_991|Drugs|Aminoglycosides|Aminoglycoside_O-nucleotidyltransferases|ANT6_1	38.6	280	288	286	2.87e-67	210
ShaoY_2019_ERR3404634_bin.2_k119_744_9	SARG|gi|754290639|ref|WP_041850110.1|	38.2	280	288	284	3.82e-67	209
ShaoY_2019_ERR3404634_bin.2_k119_947_11	CARD|gb|BAD59497.1|ARO:3000501|rpoB2	55.2	1193	1205	1162	0.0	1197
ShaoY_2019_ERR3404634_bin.2_k119_947_11	CARD|gb|WP_041777404.1|ARO:3004480|Bado_rpoB_RIF	53.0	1215	1205	1186	0.0	1174
ShaoY_2019_ERR3404634_bin.2_k119_947_11	megares|MEG_8674|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB_1	53.0	1215	1205	1186	0.0	1174
ShaoY_2019_ERR3404634_bin.2_k119_1177_22	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	40.3	484	595	579	4.06e-107	333
ShaoY_2019_ERR3404634_bin.2_k119_1177_22	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	39.7	484	595	579	5.77e-103	322
ShaoY_2019_ERR3404634_bin.2_k119_1177_22	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	40.6	488	595	578	1.43e-99	313
ShaoY_2019_ERR3404634_bin.2_k119_1177_22	SARG|gb|WP_104671188.1|ARO:3003948|efrA	29.8	578	595	575	3.84e-77	254
ShaoY_2019_ERR3404634_bin.2_k119_1177_22	SARG|gb|AYV52072.1|ARO:3002882|lmrD	33.7	487	595	664	3.97e-73	246
ShaoY_2019_ERR3404634_bin.2_k119_1177_22	SARG|gb|AAC74000.1|ARO:3003950|msbA	31.1	573	595	582	1.41e-72	242
ShaoY_2019_ERR3404634_bin.2_k119_1177_22	SARG|gb|AAK76136.1|ARO:3000025|patB	31.8	488	595	588	6.26e-71	238
ShaoY_2019_ERR3404634_bin.2_k119_1177_22	SARG|gi|662129758|ref|WP_030081404.1|	29.0	587	595	605	2.50e-68	231
ShaoY_2019_ERR3404634_bin.2_k119_1177_22	SARG|gi|664085850|ref|WP_030624018.1|	29.0	587	595	605	3.48e-68	231
ShaoY_2019_ERR3404634_bin.2_k119_1177_22	SARG|gi|505420018|ref|WP_015607120.1|	29.5	590	595	603	4.64e-68	231
ShaoY_2019_ERR3404634_bin.2_k119_1177_23	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	37.0	571	584	579	4.57e-120	366
ShaoY_2019_ERR3404634_bin.2_k119_1177_23	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	36.6	571	584	579	2.00e-118	362
ShaoY_2019_ERR3404634_bin.2_k119_1177_23	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	34.3	575	584	574	2.72e-110	340
ShaoY_2019_ERR3404634_bin.2_k119_1177_23	SARG|gi|948137056|ref|WP_056795395.1|	32.6	503	584	602	8.67e-73	243
ShaoY_2019_ERR3404634_bin.2_k119_1177_23	SARG|gi|695887424|ref|WP_032788534.1|	33.1	487	584	605	1.29e-72	243
ShaoY_2019_ERR3404634_bin.2_k119_1177_23	SARG|gb|AAK76137.1|ARO:3000024|patA	31.2	513	584	564	1.98e-72	241
ShaoY_2019_ERR3404634_bin.2_k119_1177_23	SARG|gi|1045390184|ref|WP_065479071.1|	32.9	487	584	605	2.51e-72	242
ShaoY_2019_ERR3404634_bin.2_k119_1177_23	SARG|gi|664180077|ref|WP_030714054.1|	32.9	487	584	605	2.51e-72	242
ShaoY_2019_ERR3404634_bin.2_k119_1177_23	SARG|gi|695842130|ref|WP_032755430.1|	33.3	487	584	603	3.35e-72	241
ShaoY_2019_ERR3404634_bin.2_k119_1177_23	SARG|gi|505420018|ref|WP_015607120.1|	33.3	487	584	603	4.68e-72	241
ShaoY_2019_ERR3404634_bin.2_k119_1177_31	SARG|gb|QHW12375.1|ARO:3005087|msrF	27.6	203	231	486	1.59e-09	56.2
ShaoY_2019_ERR3404634_bin.2_k119_1199_6	SARG|gi|498521217|ref|WP_010821069.1|	99.6	498	499	498	0.0	949
ShaoY_2019_ERR3404634_bin.2_k119_1199_6	SARG|gi|488319039|ref|WP_002388424.1|	99.4	498	499	498	0.0	949
ShaoY_2019_ERR3404634_bin.2_k119_1199_6	SARG|gi|498397181|ref|WP_010710665.1|	99.4	498	499	498	0.0	948
ShaoY_2019_ERR3404634_bin.2_k119_1199_6	SARG|ZP_04437889	99.4	498	499	498	0.0	948
ShaoY_2019_ERR3404634_bin.2_k119_1199_6	SARG|gi|488322547|ref|WP_002391932.1|	99.2	498	499	498	0.0	948
ShaoY_2019_ERR3404634_bin.2_k119_1199_6	SARG|gi|488324747|ref|WP_002394132.1|	99.2	498	499	498	0.0	947
ShaoY_2019_ERR3404634_bin.2_k119_1199_6	SARG|ZP_04433622	99.0	498	499	498	0.0	947
ShaoY_2019_ERR3404634_bin.2_k119_1199_6	SARG|gi|498520345|ref|WP_010820225.1|	99.2	498	499	498	0.0	947
ShaoY_2019_ERR3404634_bin.2_k119_1199_6	SARG|gi|498528849|ref|WP_010828356.1|	99.2	498	499	498	0.0	946
ShaoY_2019_ERR3404634_bin.2_k119_1199_6	SARG|gi|488327681|ref|WP_002397066.1|	99.0	498	499	498	0.0	946
ShaoY_2019_ERR3404634_bin.2_k119_1199_36	NCBI|XSG12257.1|1|1|drcB|drcB||1|||daptomycin_efflux_ABC_transporter_permease_DrcB|AMR|peptide	25.6	726	699	641	4.77e-48	178
ShaoY_2019_ERR3404634_bin.2_k119_1199_37	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	56.9	255	256	255	1.90e-98	287
ShaoY_2019_ERR3404634_bin.2_k119_1199_37	SARG|gb|AAV85982.1|ARO:3000535|macB	38.6	223	256	644	9.77e-47	163
ShaoY_2019_ERR3404634_bin.2_k119_1199_37	SARG|gi|895736250|emb|COF64653.1|	29.7	239	256	309	7.66e-27	104
ShaoY_2019_ERR3404634_bin.2_k119_1199_37	SARG|gi|446110087|ref|WP_000187942.1|	29.7	239	256	309	7.66e-27	104
ShaoY_2019_ERR3404634_bin.2_k119_1199_37	SARG|gi|445996714|ref|WP_000074569.1|	29.7	239	256	309	7.66e-27	104
ShaoY_2019_ERR3404634_bin.2_k119_1199_37	SARG|gi|445996719|ref|WP_000074574.1|	29.7	249	256	309	2.87e-26	103
ShaoY_2019_ERR3404634_bin.2_k119_1199_37	SARG|gi|507023808|ref|WP_016095885.1|	30.6	235	256	309	5.56e-26	102
ShaoY_2019_ERR3404634_bin.2_k119_1199_37	SARG|gi|1043490477|ref|WP_065382463.1|	29.8	235	256	309	7.73e-26	102
ShaoY_2019_ERR3404634_bin.2_k119_1199_37	SARG|gi|445996726|ref|WP_000074581.1|	29.8	235	256	309	7.73e-26	102
ShaoY_2019_ERR3404634_bin.2_k119_1199_37	SARG|gi|445996723|ref|WP_000074578.1|	29.8	235	256	309	7.73e-26	102
ShaoY_2019_ERR3404634_bin.2_k119_1199_42	SARG|gi|896106549|ref|WP_049136608.1|	34.3	201	221	646	2.89e-21	90.5
ShaoY_2019_ERR3404634_bin.2_k119_1199_42	SARG|gi|654544841|ref|WP_028012549.1|	33.8	201	221	646	3.92e-21	90.1
ShaoY_2019_ERR3404634_bin.2_k119_1199_42	SARG|gi|829942568|ref|WP_047368199.1|	33.8	201	221	646	3.92e-21	90.1
ShaoY_2019_ERR3404634_bin.2_k119_1199_42	SARG|gi|782756348|ref|WP_045630015.1|	34.3	201	221	646	5.32e-21	89.7
ShaoY_2019_ERR3404634_bin.2_k119_1199_42	SARG|gi|754493745|ref|WP_041910640.1|	33.8	201	221	646	7.22e-21	89.4
ShaoY_2019_ERR3404634_bin.2_k119_1199_42	SARG|gi|736472622|ref|WP_034494292.1|	33.3	201	221	648	9.81e-21	89.0
ShaoY_2019_ERR3404634_bin.2_k119_1199_42	SARG|gi|974588181|ref|WP_059178476.1|	33.8	201	221	646	1.33e-20	88.6
ShaoY_2019_ERR3404634_bin.2_k119_1199_42	SARG|YP_001176128	33.8	201	221	646	1.33e-20	88.6
ShaoY_2019_ERR3404634_bin.2_k119_1199_42	SARG|gi|498115003|ref|WP_010429159.1|	33.3	201	221	646	2.45e-20	87.8
ShaoY_2019_ERR3404634_bin.2_k119_1199_42	SARG|gi|829911593|ref|WP_047362788.1|	33.3	201	221	646	3.33e-20	87.4
ShaoY_2019_ERR3404634_bin.2_k119_1199_52	SARG|gb|AEO25219.1|ARO:3004651|lin	23.4	205	453	523	5.61e-08	53.9
ShaoY_2019_ERR3404634_bin.2_k119_1199_55	SARG|CP003583.1.gene510.p01	61.5	455	454	457	5.22e-181	512
ShaoY_2019_ERR3404634_bin.2_k119_1199_55	SARG|ZP_03589930	32.0	466	454	477	7.26e-67	220
ShaoY_2019_ERR3404634_bin.2_k119_1199_55	megares|MEG_3595|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|LMRB_1	32.0	466	454	477	7.26e-67	220
ShaoY_2019_ERR3404634_bin.2_k119_1199_55	SARG|O35018	32.0	466	454	479	7.62e-67	220
ShaoY_2019_ERR3404634_bin.2_k119_1199_55	SARG|gi|384930133|gb|AFI26811.1|	31.5	466	454	477	5.51e-66	218
ShaoY_2019_ERR3404634_bin.2_k119_1199_55	SARG|gi|498485855|ref|WP_010787543.1|	34.4	418	454	476	1.06e-65	217
ShaoY_2019_ERR3404634_bin.2_k119_1199_55	SARG|gi|504288593|ref|WP_014475695.1|	31.8	466	454	477	2.13e-65	216
ShaoY_2019_ERR3404634_bin.2_k119_1199_55	SARG|gi|503878543|ref|WP_014112537.1|	32.3	467	454	477	5.85e-65	215
ShaoY_2019_ERR3404634_bin.2_k119_1199_55	SARG|gi|695815041|ref|WP_032728901.1|	31.8	466	454	479	8.59e-65	215
ShaoY_2019_ERR3404634_bin.2_k119_1199_55	SARG|gi|566055109|gb|AHC40857.1|	31.8	466	454	477	1.79e-62	209
ShaoY_2019_ERR3404634_bin.2_k119_1199_56	SARG|gb|CAA78046.1|ARO:3002701|Rfas_cmr	30.2	348	397	391	1.48e-36	136
ShaoY_2019_ERR3404634_bin.2_k119_1199_56	megares|MEG_1781|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	30.2	348	397	391	1.48e-36	136
ShaoY_2019_ERR3404634_bin.2_k119_1199_56	megares|MEG_1780|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	29.4	347	397	391	1.48e-36	136
ShaoY_2019_ERR3404634_bin.2_k119_1199_56	SARG|AF015087.1.gene1.p01	29.4	347	397	391	1.48e-36	136
ShaoY_2019_ERR3404634_bin.2_k119_1199_56	SARG|NP_044444	31.0	268	397	391	2.79e-35	132
ShaoY_2019_ERR3404634_bin.2_k119_1199_56	SARG|AF024666.2.gene33.p01	31.0	268	397	391	2.79e-35	132
ShaoY_2019_ERR3404634_bin.2_k119_1199_56	SARG|gi|2708772|gb|AAB96371.1|	31.0	268	397	391	5.34e-35	132
ShaoY_2019_ERR3404634_bin.2_k119_1199_56	SARG|YP_251195	31.0	268	397	391	5.34e-35	132
ShaoY_2019_ERR3404634_bin.2_k119_1274_23	megares|MEG_1289|Drugs|beta-lactam|Penicillin_binding_protein_regulator|BLAI_1	30.8	117	152	126	2.39e-16	69.7
ShaoY_2019_ERR3404634_bin.2_k119_1274_30	CARD|gb|AAD51347.1|ARO:3003067|smeS	31.3	307	465	467	2.22e-39	147
ShaoY_2019_ERR3404634_bin.2_k119_1274_30	CARD|gb|AEX49906.1|ARO:3003583|basS	28.1	278	465	477	7.25e-25	105
ShaoY_2019_ERR3404634_bin.2_k119_1274_30	megares|MEG_7514|Drugs|Glycopeptide|VanL-type_regulator|VANSL_1	31.0	252	465	364	2.13e-21	94.4
ShaoY_2019_ERR3404634_bin.2_k119_1274_30	NCBI|WP_063856745.1|1|1|vanS-L|vanS-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-L|AMR|glycopeptide	31.0	252	465	364	2.13e-21	94.4
ShaoY_2019_ERR3404634_bin.2_k119_1274_30	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	26.9	234	465	359	3.32e-19	87.8
ShaoY_2019_ERR3404634_bin.2_k119_1274_30	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	26.5	230	465	357	6.78e-17	80.9
ShaoY_2019_ERR3404634_bin.2_k119_1274_30	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	26.5	230	465	357	6.78e-17	80.9
ShaoY_2019_ERR3404634_bin.2_k119_1274_31	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	42.9	226	227	232	6.46e-56	177
ShaoY_2019_ERR3404634_bin.2_k119_1274_31	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	42.9	226	227	232	6.46e-56	177
ShaoY_2019_ERR3404634_bin.2_k119_1274_31	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	41.8	225	227	231	5.04e-55	174
ShaoY_2019_ERR3404634_bin.2_k119_1274_31	CARD|gb|AAG05188.1|ARO:3005068|ParR	40.4	223	227	235	1.29e-53	171
ShaoY_2019_ERR3404634_bin.2_k119_1274_31	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	41.0	227	227	231	1.84e-52	168
ShaoY_2019_ERR3404634_bin.2_k119_1274_31	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	41.0	227	227	231	3.67e-52	167
ShaoY_2019_ERR3404634_bin.2_k119_1274_31	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	40.8	228	227	235	5.84e-52	167
ShaoY_2019_ERR3404634_bin.2_k119_1274_31	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	41.2	228	227	239	6.56e-52	167
ShaoY_2019_ERR3404634_bin.2_k119_1274_31	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	39.6	225	227	231	7.34e-52	166
ShaoY_2019_ERR3404634_bin.2_k119_1274_31	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	39.6	225	227	231	7.34e-52	166
ShaoY_2019_ERR3404634_bin.2_k119_1274_56	SARG|ABB70049	100	639	640	639	0.0	1265
ShaoY_2019_ERR3404634_bin.2_k119_1274_56	SARG|ABP89888	100	639	640	644	0.0	1265
ShaoY_2019_ERR3404634_bin.2_k119_1274_56	SARG|gi|164612278|gb|ABY63608.1|	99.8	639	640	639	0.0	1265
ShaoY_2019_ERR3404634_bin.2_k119_1274_56	SARG|ABB18304	98.0	639	640	639	0.0	1244
ShaoY_2019_ERR3404634_bin.2_k119_1274_56	SARG|ABB70056	98.0	639	640	639	0.0	1242
ShaoY_2019_ERR3404634_bin.2_k119_1274_56	SARG|CAJ00301	98.3	639	640	639	0.0	1241
ShaoY_2019_ERR3404634_bin.2_k119_1274_56	SARG|CAJ00297	97.3	639	640	639	0.0	1231
ShaoY_2019_ERR3404634_bin.2_k119_1274_56	SARG|ABW24731	96.4	639	640	639	0.0	1221
ShaoY_2019_ERR3404634_bin.2_k119_1274_56	SARG|ABB70047	96.1	639	640	639	0.0	1220
ShaoY_2019_ERR3404634_bin.2_k119_1274_56	SARG|ABB70053	95.9	639	640	639	0.0	1219
ShaoY_2019_ERR3404634_bin.2_k119_1274_57	SARG|CAI84881	100	458	459	458	1.39e-319	863
ShaoY_2019_ERR3404634_bin.2_k119_1274_57	SARG|AAL92527	99.8	458	459	458	3.48e-319	862
ShaoY_2019_ERR3404634_bin.2_k119_1274_57	megares|MEG_7101|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETL_1	99.8	458	459	458	4.88e-319	862
ShaoY_2019_ERR3404634_bin.2_k119_1274_57	SARG|M11036.gene.p01	99.8	458	459	458	9.76e-319	861
ShaoY_2019_ERR3404634_bin.2_k119_1274_57	SARG|gi|1043724887|gb|ANS91860.1|	99.8	458	459	458	9.76e-319	861
ShaoY_2019_ERR3404634_bin.2_k119_1274_57	megares|MEG_7097|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETL_1	99.6	458	459	458	1.39e-318	861
ShaoY_2019_ERR3404634_bin.2_k119_1274_57	megares|MEG_7096|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETL_1	99.6	458	459	458	3.90e-318	860
ShaoY_2019_ERR3404634_bin.2_k119_1274_57	SARG|CAA43220	98.3	458	459	458	8.41e-313	846
ShaoY_2019_ERR3404634_bin.2_k119_1274_57	megares|MEG_7100|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETL_1	98.0	458	459	458	3.42e-312	845
ShaoY_2019_ERR3404634_bin.2_k119_1274_57	SARG|P13924	98.5	458	459	458	1.39e-311	843
ShaoY_2019_ERR3404634_bin.2_k119_1274_59	SARG|M90091.1.gene2.p01	97.2	215	216	215	8.20e-159	436
ShaoY_2019_ERR3404634_bin.2_k119_1274_59	SARG|YP_001429537	96.7	215	216	215	3.34e-158	435
ShaoY_2019_ERR3404634_bin.2_k119_1274_59	SARG|M58515.1.gene2.p01	92.1	214	216	219	2.21e-148	410
ShaoY_2019_ERR3404634_bin.2_k119_1274_59	SARG|AY355285.1.gene3.p01	89.3	215	216	215	2.72e-148	410
ShaoY_2019_ERR3404634_bin.2_k119_1274_59	SARG|M58516.1.gene2.p01	88.0	208	216	209	1.86e-140	390
ShaoY_2019_ERR3404634_bin.2_k119_1274_59	SARG|X02529.1.gene3.p1	79.5	215	216	215	8.59e-136	378
ShaoY_2019_ERR3404634_bin.2_k119_1274_59	SARG|U83488.1.gene4.p01	79.1	215	216	215	1.00e-134	375
ShaoY_2019_ERR3404634_bin.2_k119_1274_59	SARG|X02872.1.gene2.p1	78.6	215	216	215	1.00e-134	375
ShaoY_2019_ERR3404634_bin.2_k119_1274_59	SARG|M64281.gene.p01	78.6	215	216	215	2.02e-134	375
ShaoY_2019_ERR3404634_bin.2_k119_1274_59	SARG|X60827.1.gene2.p01	78.6	215	216	215	5.79e-134	374
ShaoY_2019_ERR3404634_bin.2_k119_1340_14	SARG|gi|1035706844|ref|WP_064548272.1|	30.3	89	940	648	6.53e-06	48.9
ShaoY_2019_ERR3404634_bin.2_k119_1340_17	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	38.1	252	246	255	1.22e-46	154
ShaoY_2019_ERR3404634_bin.2_k119_1340_17	SARG|gi|1035670474|ref|WP_064517458.1|	37.5	224	246	648	6.70e-39	141
ShaoY_2019_ERR3404634_bin.2_k119_1340_17	SARG|gi|1035717981|ref|WP_064557480.1|	37.5	224	246	648	6.70e-39	141
ShaoY_2019_ERR3404634_bin.2_k119_1340_17	SARG|gb|ADZ12699.1|ARO:3005091|RanA	33.8	237	246	258	4.11e-38	132
ShaoY_2019_ERR3404634_bin.2_k119_1340_17	SARG|gi|803568669|ref|WP_046077412.1|	38.6	202	246	648	1.60e-37	137
ShaoY_2019_ERR3404634_bin.2_k119_1340_17	SARG|gi|446110352|ref|WP_000188207.1|	38.6	202	246	648	1.60e-37	137
ShaoY_2019_ERR3404634_bin.2_k119_1340_17	SARG|YP_002382193	38.6	202	246	648	1.60e-37	137
ShaoY_2019_ERR3404634_bin.2_k119_1340_17	SARG|gi|803575554|ref|WP_046081557.1|	38.6	202	246	648	1.60e-37	137
ShaoY_2019_ERR3404634_bin.2_k119_1340_17	SARG|gi|446110351|ref|WP_000188206.1|	38.6	202	246	648	1.60e-37	137
ShaoY_2019_ERR3404634_bin.2_k119_1340_17	SARG|gi|1035706844|ref|WP_064548272.1|	37.9	214	246	648	3.01e-37	137
ShaoY_2019_ERR3404634_bin.2_k119_1340_30	SARG|gi|752536579|ref|WP_041208093.1|	23.3	322	389	382	6.06e-11	62.4
ShaoY_2019_ERR3404634_bin.2_k119_1340_30	SARG|gi|760168508|ref|WP_043849334.1|	23.0	322	389	382	1.91e-10	60.8
ShaoY_2019_ERR3404634_bin.2_k119_1340_30	SARG|gb|WP_023874922.1|ARO:3005292|PDC-19b	34.1	91	389	397	8.25e-09	55.8
ShaoY_2019_ERR3404634_bin.2_k119_1340_30	SARG|gb|WP_063864589.1|ARO:3006852|PDC-99	34.1	91	389	397	8.25e-09	55.8
ShaoY_2019_ERR3404634_bin.2_k119_1340_30	NCBI|WP_063840463.1|1|1|ampC_Asob|ampC_Asob|hydrolase|2|CEPHALOSPORIN|beta-lactam|FOX/MOX_family_cephalosporin-hydrolyzing_class_C_beta-lactamase|AMR|beta-lactam	25.7	148	389	382	2.48e-08	54.3
ShaoY_2019_ERR3404634_bin.2_k119_1340_30	NCBI|WP_128268282.1|1|1|blaRSC1-1|blaRSC1|hydrolase|2|CEPHALOSPORIN|beta-lactam|class_C_beta-lactamase_RSC1-1|AMR|beta-lactam	26.9	160	389	396	3.42e-08	53.9
ShaoY_2019_ERR3404634_bin.2_k119_1350_23	SARG|gb|WP_104671188.1|ARO:3003948|efrA	38.1	564	576	575	2.57e-122	371
ShaoY_2019_ERR3404634_bin.2_k119_1350_23	SARG|gb|AAK76137.1|ARO:3000024|patA	30.8	565	576	564	1.64e-90	288
ShaoY_2019_ERR3404634_bin.2_k119_1350_23	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	34.1	487	576	579	3.55e-68	230
ShaoY_2019_ERR3404634_bin.2_k119_1350_23	SARG|gi|860594225|ref|WP_048475168.1|	28.6	569	576	620	4.24e-68	231
ShaoY_2019_ERR3404634_bin.2_k119_1350_23	SARG|gi|917229923|ref|WP_051836635.1|	30.9	538	576	620	5.90e-68	230
ShaoY_2019_ERR3404634_bin.2_k119_1350_23	SARG|gi|917166849|ref|WP_051773561.1|	31.0	538	576	620	5.90e-68	230
ShaoY_2019_ERR3404634_bin.2_k119_1350_23	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	33.5	487	576	579	6.89e-68	229
ShaoY_2019_ERR3404634_bin.2_k119_1350_23	SARG|gi|917155568|ref|WP_051762280.1|	31.0	538	576	620	8.21e-68	230
ShaoY_2019_ERR3404634_bin.2_k119_1350_23	SARG|gi|926351744|ref|WP_053683383.1|	30.9	538	576	648	1.01e-67	230
ShaoY_2019_ERR3404634_bin.2_k119_1350_23	SARG|gi|926294973|ref|WP_053631154.1|	31.0	538	576	620	2.21e-67	229
ShaoY_2019_ERR3404634_bin.2_k119_1350_24	SARG|gb|AAK76136.1|ARO:3000025|patB	35.0	585	589	588	6.66e-98	309
ShaoY_2019_ERR3404634_bin.2_k119_1350_24	SARG|gb|AYV52072.1|ARO:3002882|lmrD	34.7	501	589	664	2.72e-89	288
ShaoY_2019_ERR3404634_bin.2_k119_1350_24	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	33.3	583	589	579	1.08e-87	282
ShaoY_2019_ERR3404634_bin.2_k119_1350_24	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	34.3	583	589	579	2.99e-87	281
ShaoY_2019_ERR3404634_bin.2_k119_1350_24	SARG|gi|1045390184|ref|WP_065479071.1|	30.7	576	589	605	2.32e-85	276
ShaoY_2019_ERR3404634_bin.2_k119_1350_24	SARG|gi|497748188|ref|WP_010062372.1|	30.9	576	589	605	3.24e-85	276
ShaoY_2019_ERR3404634_bin.2_k119_1350_24	SARG|gi|772774655|ref|WP_045322518.1|	31.2	570	589	620	9.08e-85	275
ShaoY_2019_ERR3404634_bin.2_k119_1350_24	SARG|gi|664180077|ref|WP_030714054.1|	30.9	576	589	605	1.75e-84	274
ShaoY_2019_ERR3404634_bin.2_k119_1350_24	SARG|gi|764446018|ref|WP_044369325.1|	30.7	576	589	605	2.45e-84	274
ShaoY_2019_ERR3404634_bin.2_k119_1350_24	SARG|gb|AAC74000.1|ARO:3003950|msbA	31.2	584	589	582	2.75e-84	273
ShaoY_2019_ERR3404634_bin.2_k119_1350_29	SARG|P07287	34.7	196	296	381	2.40e-20	89.0
ShaoY_2019_ERR3404634_bin.2_k119_1350_29	megares|MEG_2827|Drugs|MLS|23S_rRNA_methyltransferases|ERME_1	34.7	196	296	381	2.40e-20	89.0
ShaoY_2019_ERR3404634_bin.2_k119_1350_29	ResF|erm(A)_3_EU348758_1	30.3	198	296	243	4.52e-17	77.8
ShaoY_2019_ERR3404634_bin.2_k119_1350_29	SARG|YP_002201843	31.6	196	296	258	2.30e-12	64.7
ShaoY_2019_ERR3404634_bin.2_k119_1350_29	SARG|gb|OPG86592.1|ARO:3004626|Erm(49)	23.6	233	296	304	4.59e-12	64.3
ShaoY_2019_ERR3404634_bin.2_k119_1350_29	megares|MEG_2786|Drugs|MLS|23S_rRNA_methyltransferases|ERMA_1	29.7	175	296	198	1.27e-11	61.6
ShaoY_2019_ERR3404634_bin.2_k119_1350_29	SARG|gb|AAC69328.1|ARO:3001265|Erm(30)	30.1	216	296	336	2.44e-11	62.4
ShaoY_2019_ERR3404634_bin.2_k119_1350_32	NCBI|CCA59315.1|1|1|helR|helR||1|rifamycin|rifamycin|RNA_polymerase_recycling_motor_ATPase_HelR|AMR|rifamycin	29.2	192	733	722	1.04e-12	70.5
ShaoY_2019_ERR3404634_bin.2_k119_1350_35	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	31.3	112	670	1024	7.10e-07	51.6
ShaoY_2019_ERR3404634_bin.2_k119_1350_35	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	31.3	112	670	1024	7.10e-07	51.6
ShaoY_2019_ERR3404634_bin.2_k119_1350_35	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	31.3	112	670	1024	7.10e-07	51.6
ShaoY_2019_ERR3404634_bin.2_k119_1350_35	SARG|gb|CAA53189|ARO:3000521|mupA	31.3	112	670	1024	7.10e-07	51.6
ShaoY_2019_ERR3404634_bin.2_k119_1350_38	NCBI|XSG12258.1|1|1|drcS|drcS||1|||daptomycin_efflux_sensor_histidine_kinase_DrcS|AMR|peptide	39.6	283	342	341	2.79e-63	203
ShaoY_2019_ERR3404634_bin.2_k119_1350_39	NCBI|XSG12259.1|1|1|drcR|drcR||1|||daptomycin_efflux_response_regulator_transcription_factor_DrcR|AMR|peptide	54.3	221	225	223	4.04e-87	256
ShaoY_2019_ERR3404634_bin.2_k119_1350_39	CARD|gb|ATC67679.1|ARO:3000838|arlR	34.1	223	225	219	3.97e-39	133
ShaoY_2019_ERR3404634_bin.2_k119_1350_39	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	32.2	227	225	233	6.07e-35	123
ShaoY_2019_ERR3404634_bin.2_k119_1350_39	CARD|gb|AAD51348.1|ARO:3003066|smeR	33.6	220	225	229	7.73e-35	122
ShaoY_2019_ERR3404634_bin.2_k119_1350_39	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	31.9	226	225	231	1.25e-33	119
ShaoY_2019_ERR3404634_bin.2_k119_1350_39	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	32.2	230	225	235	1.38e-33	119
ShaoY_2019_ERR3404634_bin.2_k119_1350_39	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	32.3	229	225	239	1.18e-32	117
ShaoY_2019_ERR3404634_bin.2_k119_1350_39	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	29.2	226	225	231	7.54e-32	115
ShaoY_2019_ERR3404634_bin.2_k119_1350_39	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	29.6	226	225	231	2.10e-31	114
ShaoY_2019_ERR3404634_bin.2_k119_1350_39	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	29.6	226	225	231	2.10e-31	114
ShaoY_2019_ERR3404634_bin.2_k119_1350_42	CARD|gb|CAA79966.1|ARO:3003665|NmcR	31.2	109	277	295	7.06e-07	48.5
ShaoY_2019_ERR3404634_bin.2_k119_1350_53	SARG|gb|ADZ12699.1|ARO:3005091|RanA	30.7	225	319	258	5.59e-31	116
ShaoY_2019_ERR3404634_bin.2_k119_1350_53	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	30.4	230	319	255	7.94e-27	105
ShaoY_2019_ERR3404634_bin.2_k119_1350_54	SARG|gi|974672242|ref|WP_059256507.1|	35.7	241	353	648	7.09e-28	113
ShaoY_2019_ERR3404634_bin.2_k119_1350_54	SARG|gi|974641719|ref|WP_059227752.1|	35.7	241	353	648	7.09e-28	113
ShaoY_2019_ERR3404634_bin.2_k119_1350_54	SARG|gi|643601187|ref|WP_025237288.1|	35.7	241	353	648	7.09e-28	113
ShaoY_2019_ERR3404634_bin.2_k119_1350_54	SARG|gi|974628291|ref|WP_059215695.1|	35.7	241	353	648	7.09e-28	113
ShaoY_2019_ERR3404634_bin.2_k119_1350_54	SARG|gi|446110298|ref|WP_000188153.1|	35.7	241	353	648	7.09e-28	113
ShaoY_2019_ERR3404634_bin.2_k119_1350_54	SARG|gi|446110299|ref|WP_000188154.1|	35.7	241	353	648	7.09e-28	113
ShaoY_2019_ERR3404634_bin.2_k119_1350_54	SARG|ZP_02903696	35.7	241	353	648	7.09e-28	113
ShaoY_2019_ERR3404634_bin.2_k119_1350_54	SARG|gi|974633183|ref|WP_059219858.1|	35.7	241	353	648	7.09e-28	113
ShaoY_2019_ERR3404634_bin.2_k119_1350_54	SARG|gi|974684692|ref|WP_059267998.1|	35.7	241	353	648	7.09e-28	113
ShaoY_2019_ERR3404634_bin.2_k119_1350_54	SARG|gi|974688082|ref|WP_059271287.1|	35.7	241	353	648	7.09e-28	113
ShaoY_2019_ERR3404634_bin.2_k119_1350_71	SARG|gi|1035670474|ref|WP_064517458.1|	37.2	250	241	648	2.67e-42	150
ShaoY_2019_ERR3404634_bin.2_k119_1350_71	SARG|gi|1035717981|ref|WP_064557480.1|	37.2	250	241	648	2.67e-42	150
ShaoY_2019_ERR3404634_bin.2_k119_1350_71	SARG|gi|736472622|ref|WP_034494292.1|	36.8	250	241	648	4.78e-41	147
ShaoY_2019_ERR3404634_bin.2_k119_1350_71	SARG|gi|896106549|ref|WP_049136608.1|	38.6	228	241	646	8.95e-41	146
ShaoY_2019_ERR3404634_bin.2_k119_1350_71	SARG|gi|654544841|ref|WP_028012549.1|	38.6	228	241	646	1.23e-40	146
ShaoY_2019_ERR3404634_bin.2_k119_1350_71	SARG|gi|895872463|ref|WP_048979698.1|	39.0	228	241	646	1.23e-40	146
ShaoY_2019_ERR3404634_bin.2_k119_1350_71	SARG|gi|851931792|ref|WP_048222288.1|	38.6	228	241	646	2.34e-40	145
ShaoY_2019_ERR3404634_bin.2_k119_1350_71	SARG|gi|798937928|ref|WP_045908399.1|	38.6	228	241	646	2.34e-40	145
ShaoY_2019_ERR3404634_bin.2_k119_1350_71	SARG|gi|695748190|ref|WP_032674455.1|	38.6	228	241	646	3.21e-40	145
ShaoY_2019_ERR3404634_bin.2_k119_1350_71	SARG|gi|779866095|ref|WP_045354445.1|	38.6	228	241	646	3.21e-40	145
ShaoY_2019_ERR3404634_bin.2_k119_1350_76	SARG|gb|AAC75314.1|ARO:3003578|pmrF	33.1	136	421	322	9.69e-07	49.3
ShaoY_2019_ERR3404634_bin.2_k119_1350_95	SARG|gi|555268037|ref|WP_023249477.1|	33.3	222	395	648	7.18e-32	126
ShaoY_2019_ERR3404634_bin.2_k119_1350_95	SARG|gi|924626178|ref|WP_053530123.1|	33.3	222	395	648	9.73e-32	125
ShaoY_2019_ERR3404634_bin.2_k119_1350_95	SARG|gi|696368937|ref|WP_032943949.1|	30.6	229	395	648	1.32e-31	125
ShaoY_2019_ERR3404634_bin.2_k119_1350_95	SARG|gi|554685678|ref|WP_023185565.1|	33.8	222	395	648	1.32e-31	125
ShaoY_2019_ERR3404634_bin.2_k119_1350_95	SARG|YP_001571041	31.1	222	395	648	1.79e-31	125
ShaoY_2019_ERR3404634_bin.2_k119_1350_95	SARG|gi|696361545|ref|WP_032936694.1|	30.6	229	395	648	1.79e-31	125
ShaoY_2019_ERR3404634_bin.2_k119_1350_95	SARG|gi|960873409|ref|WP_058345546.1|	31.1	222	395	648	1.79e-31	125
ShaoY_2019_ERR3404634_bin.2_k119_1350_95	SARG|gi|740610794|ref|WP_038396317.1|	31.1	222	395	648	2.42e-31	124
ShaoY_2019_ERR3404634_bin.2_k119_1350_95	SARG|gi|446048013|ref|WP_000125868.1|	31.4	223	395	648	3.28e-31	124
ShaoY_2019_ERR3404634_bin.2_k119_1350_95	SARG|gi|924503108|ref|WP_053510027.1|	32.9	222	395	648	3.28e-31	124
ShaoY_2019_ERR3404634_bin.2_k119_1350_111	SARG|gb|ABA71733.1|ARO:3002972|vanTG	34.2	368	372	712	1.75e-55	192
ShaoY_2019_ERR3404634_bin.2_k119_1350_111	NCBI|WP_063856752.1|1|1|vanT-G|vanT-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-G|AMR|glycopeptide	31.1	366	372	711	5.54e-43	157
ShaoY_2019_ERR3404634_bin.2_k119_1350_111	SARG|gb|ABX54690.1|ARO:3002974|vanTrL	29.0	365	372	366	7.60e-38	138
ShaoY_2019_ERR3404634_bin.2_k119_1350_111	NCBI|WP_063856756.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	31.2	362	372	700	1.38e-33	130
ShaoY_2019_ERR3404634_bin.2_k119_1350_111	NCBI|WP_063856755.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	31.6	361	372	700	1.16e-32	128
ShaoY_2019_ERR3404634_bin.2_k119_1350_111	NCBI|WP_063856759.1|1|1|vanTc3|vanTc3|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT|AMR|glycopeptide	32.9	316	372	700	1.78e-31	124
ShaoY_2019_ERR3404634_bin.2_k119_1350_111	NCBI|WP_063856758.1|1|1|vanTc2|vanTc2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT|AMR|glycopeptide	30.5	361	372	706	1.80e-31	124
ShaoY_2019_ERR3404634_bin.2_k119_1350_114	megares|MEG_7571|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	30.5	442	458	451	1.44e-56	192
ShaoY_2019_ERR3404634_bin.2_k119_1350_114	megares|MEG_7572|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	29.5	441	458	481	2.11e-54	187
ShaoY_2019_ERR3404634_bin.2_k119_1350_114	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_2	28.8	438	458	451	8.45e-53	182
ShaoY_2019_ERR3404634_bin.2_k119_1350_115	SARG|gb|ABX54687.1|ARO:3002910|vanL	35.6	357	357	349	2.34e-68	217
ShaoY_2019_ERR3404634_bin.2_k119_1350_115	SARG|gi|498467695|ref|WP_010773051.1|	35.2	352	357	352	7.60e-64	206
ShaoY_2019_ERR3404634_bin.2_k119_1350_115	SARG|gi|1028100553|ref|WP_063856688.1|	37.9	351	357	343	3.29e-63	204
ShaoY_2019_ERR3404634_bin.2_k119_1350_115	SARG|JF802084.2.gene1.p01	34.9	347	357	343	3.29e-63	204
ShaoY_2019_ERR3404634_bin.2_k119_1350_115	SARG|gi|748755610|ref|WP_040013725.1|	37.9	351	357	343	4.64e-63	203
ShaoY_2019_ERR3404634_bin.2_k119_1350_115	SARG|AF162694.1.gene2.p01	37.9	351	357	343	4.64e-63	203
ShaoY_2019_ERR3404634_bin.2_k119_1350_115	SARG|gi|355380870|gb|EHG28002.1|	37.9	351	357	344	4.77e-63	203
ShaoY_2019_ERR3404634_bin.2_k119_1350_115	SARG|gi|257803688|gb|EEV32510.1|	37.9	351	357	344	4.77e-63	203
ShaoY_2019_ERR3404634_bin.2_k119_1350_115	SARG|gi|751652141|ref|WP_041119007.1|	37.9	351	357	343	6.54e-63	203
ShaoY_2019_ERR3404634_bin.2_k119_1350_115	SARG|gi|1028100552|ref|WP_063856687.1|	37.9	351	357	343	6.54e-63	203
ShaoY_2019_ERR3404634_bin.2_k119_1648_5	SARG|GQ205627.2.gene3.p01	42.7	110	213	216	2.34e-15	70.9
ShaoY_2019_ERR3404634_bin.2_k119_1648_5	SARG|gi|499386493|ref|WP_011073960.1|	40.5	111	213	210	2.94e-15	70.5
ShaoY_2019_ERR3404634_bin.2_k119_1648_5	SARG|gb|AID93387.1|ARO:3004660|catB11	40.2	112	213	210	7.69e-14	66.6
ShaoY_2019_ERR3404634_bin.2_k119_1648_5	SARG|AJ223604.1.gene5.p01	36.9	111	213	210	1.47e-13	65.9
ShaoY_2019_ERR3404634_bin.2_k119_1648_5	SARG|M58472.1.gene1.p01	36.5	115	213	209	2.01e-13	65.5
ShaoY_2019_ERR3404634_bin.2_k119_1648_5	SARG|ABF20240	40.2	112	213	210	2.04e-13	65.5
ShaoY_2019_ERR3404634_bin.2_k119_1648_5	NCBI|WP_071846363.1|1|1|catB3|catB3|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B-3_phenicol_O-acetyltransferase_CatB3|AMR|phenicol	39.3	112	213	210	2.04e-13	65.5
ShaoY_2019_ERR3404634_bin.2_k119_1648_5	SARG|ABC69169	38.8	121	213	210	2.04e-13	65.5
ShaoY_2019_ERR3404634_bin.2_k119_1648_5	SARG|CAP74085	39.3	112	213	210	2.82e-13	65.1
ShaoY_2019_ERR3404634_bin.2_k119_1648_5	SARG|ACA48664	39.3	112	213	210	2.82e-13	65.1
ShaoY_2019_ERR3404634_bin.2_k119_1648_17	SARG|gb|AVI44920.1|ARO:3004470|poxtA	23.3	236	270	542	8.53e-11	60.8
ShaoY_2019_ERR3404634_bin.2_k119_1648_17	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	23.3	236	270	544	8.54e-11	60.8
ShaoY_2019_ERR3404634_bin.2_k119_1908_17	CARD|gb|CAA79966.1|ARO:3003665|NmcR	24.1	241	295	295	4.35e-08	52.4
ShaoY_2019_ERR3404634_bin.2_k119_1908_18	SARG|U19459.gene.p01	56.9	51	194	212	1.34e-11	60.1
ShaoY_2019_ERR3404634_bin.2_k119_1908_18	SARG|M58472.1.gene1.p01	44.8	67	194	209	4.05e-09	53.1
ShaoY_2019_ERR3404634_bin.2_k119_1908_18	SARG|gb|AAF63432|ARO:3003744|vatF	46.7	45	194	221	1.16e-08	52.0
ShaoY_2019_ERR3404634_bin.2_k119_1908_18	SARG|GQ205627.2.gene3.p01	51.1	45	194	216	1.52e-08	51.6
ShaoY_2019_ERR3404634_bin.2_k119_1908_18	SARG|AF139725.gene.p01	54.5	44	194	214	2.05e-08	51.2
ShaoY_2019_ERR3404634_bin.2_k119_1908_18	SARG|AAF24171	54.5	44	194	214	2.05e-08	51.2
ShaoY_2019_ERR3404634_bin.2_k119_1908_18	NCBI|WP_063856931.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	54.5	44	194	214	2.05e-08	51.2
ShaoY_2019_ERR3404634_bin.2_k119_1908_18	NCBI|WP_063856932.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	54.5	44	194	214	2.05e-08	51.2
ShaoY_2019_ERR3404634_bin.2_k119_1908_18	NCBI|WP_063856933.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	54.5	44	194	214	2.05e-08	51.2
ShaoY_2019_ERR3404634_bin.2_k119_1908_18	NCBI|WP_063856934.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	54.5	44	194	214	2.05e-08	51.2
ShaoY_2019_ERR3404634_bin.2_k119_1908_24	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	25.2	830	881	1024	2.54e-67	242
ShaoY_2019_ERR3404634_bin.2_k119_1908_24	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	25.1	830	881	1024	4.66e-67	241
ShaoY_2019_ERR3404634_bin.2_k119_1908_24	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	25.2	830	881	1024	8.56e-67	240
ShaoY_2019_ERR3404634_bin.2_k119_1908_24	SARG|gb|CAA53189|ARO:3000521|mupA	25.1	830	881	1024	1.57e-66	239
ShaoY_2019_ERR3404634_bin.2_k119_1908_24	megares|MEG_3295|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES_1	24.9	567	881	1107	4.11e-40	159
ShaoY_2019_ERR3404634_bin.2_k119_1908_24	SARG|gb|ADP36409.1|ARO:3003730|Bifidobacteria	24.9	567	881	1107	4.11e-40	159
ShaoY_2019_ERR3404634_bin.2_k119_1908_34	SARG|gb|WP_104671188.1|ARO:3003948|efrA	99.5	575	576	575	0.0	1090
ShaoY_2019_ERR3404634_bin.2_k119_1908_34	SARG|gb|AAK76137.1|ARO:3000024|patA	37.1	520	576	564	6.34e-110	339
ShaoY_2019_ERR3404634_bin.2_k119_1908_34	SARG|gb|AAC74000.1|ARO:3003950|msbA	27.8	539	576	582	1.43e-67	228
ShaoY_2019_ERR3404634_bin.2_k119_1908_34	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	28.6	584	576	579	9.77e-67	226
ShaoY_2019_ERR3404634_bin.2_k119_1908_34	SARG|gb|AYV52072.1|ARO:3002882|lmrD	29.0	528	576	664	5.03e-66	226
ShaoY_2019_ERR3404634_bin.2_k119_1908_34	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	28.9	547	576	579	3.71e-65	222
ShaoY_2019_ERR3404634_bin.2_k119_1908_34	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	29.5	580	576	579	1.00e-60	210
ShaoY_2019_ERR3404634_bin.2_k119_1908_34	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	30.3	584	576	579	1.93e-60	209
ShaoY_2019_ERR3404634_bin.2_k119_1908_34	SARG|gb|AAK76136.1|ARO:3000025|patB	27.4	497	576	588	1.13e-57	202
ShaoY_2019_ERR3404634_bin.2_k119_1908_34	SARG|gi|928900436|ref|WP_053931243.1|	28.2	550	576	600	3.47e-55	195
ShaoY_2019_ERR3404634_bin.2_k119_1908_35	SARG|gb|CDO61516.1|ARO:3003949|efrB	97.6	330	590	362	8.89e-222	617
ShaoY_2019_ERR3404634_bin.2_k119_1908_35	SARG|gb|AAK76136.1|ARO:3000025|patB	38.4	578	590	588	2.30e-121	370
ShaoY_2019_ERR3404634_bin.2_k119_1908_35	SARG|gb|AYV52072.1|ARO:3002882|lmrD	37.1	544	590	664	2.92e-112	348
ShaoY_2019_ERR3404634_bin.2_k119_1908_35	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	35.6	497	590	579	4.31e-92	293
ShaoY_2019_ERR3404634_bin.2_k119_1908_35	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	34.3	527	590	579	1.67e-91	292
ShaoY_2019_ERR3404634_bin.2_k119_1908_35	SARG|gi|948137056|ref|WP_056795395.1|	31.9	580	590	602	4.34e-85	276
ShaoY_2019_ERR3404634_bin.2_k119_1908_35	SARG|gb|AAK76137.1|ARO:3000024|patA	34.0	518	590	564	1.29e-84	273
ShaoY_2019_ERR3404634_bin.2_k119_1908_35	SARG|gi|928900436|ref|WP_053931243.1|	32.2	581	590	600	1.59e-84	274
ShaoY_2019_ERR3404634_bin.2_k119_1908_35	SARG|gi|664579989|ref|WP_031094015.1|	32.2	581	590	601	1.63e-84	274
ShaoY_2019_ERR3404634_bin.2_k119_1908_35	SARG|gb|AAC74000.1|ARO:3003950|msbA	32.4	521	590	582	3.96e-84	273
ShaoY_2019_ERR3404634_bin.2_k119_1908_43	CARD|gb|BAB36671.1|ARO:3000832|evgA	28.3	187	211	204	6.78e-17	74.7
ShaoY_2019_ERR3404634_bin.2_k119_1908_43	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	34.2	76	211	228	1.18e-06	46.6
ShaoY_2019_ERR3404634_bin.2_k119_1908_47	NCBI|WP_000052512.1|1|1|msr(E)|msr(E)|target_protection|2|AZITHROMYCIN/ERYTHROMYCIN/STREPTOGRAMIN|MACROLIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Msr(E)|AMR|multidrug	28.5	186	357	491	1.84e-07	51.6
ShaoY_2019_ERR3404634_bin.2_k119_1908_47	SARG|AAG08983	21.8	243	357	524	1.83e-06	48.5
ShaoY_2019_ERR3404634_bin.2_k119_1908_47	SARG|AAF24091	23.0	230	357	522	9.89e-06	46.2
ShaoY_2019_ERR3404634_bin.2_k119_2242_13	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	31.6	114	214	255	1.08e-14	69.7
ShaoY_2019_ERR3404634_bin.2_k119_2242_13	SARG|gi|496018010|ref|WP_008742581.1|	36.7	90	214	623	5.73e-12	63.2
ShaoY_2019_ERR3404634_bin.2_k119_2242_13	SARG|gi|860594225|ref|WP_048475168.1|	35.6	90	214	620	2.59e-11	61.2
ShaoY_2019_ERR3404634_bin.2_k119_2242_13	SARG|gi|926286457|ref|WP_053623344.1|	36.7	90	214	605	6.34e-11	60.1
ShaoY_2019_ERR3404634_bin.2_k119_2242_13	SARG|gi|662175949|ref|WP_030118884.1|	36.7	90	214	605	6.34e-11	60.1
ShaoY_2019_ERR3404634_bin.2_k119_2242_13	SARG|gi|663155409|ref|WP_030194633.1|	36.7	90	214	605	6.34e-11	60.1
ShaoY_2019_ERR3404634_bin.2_k119_2242_13	SARG|gi|664538723|ref|WP_031054357.1|	36.7	90	214	605	6.34e-11	60.1
ShaoY_2019_ERR3404634_bin.2_k119_2242_13	SARG|gi|664317010|ref|WP_030845774.1|	36.7	90	214	605	1.16e-10	59.3
ShaoY_2019_ERR3404634_bin.2_k119_2242_13	SARG|gi|663286402|ref|WP_030292859.1|	36.7	90	214	605	1.16e-10	59.3
ShaoY_2019_ERR3404634_bin.2_k119_2242_13	SARG|gi|663342223|ref|WP_030341347.1|	36.7	90	214	605	1.16e-10	59.3
ShaoY_2019_ERR3404634_bin.2_k119_2316_32	SARG|YP_808159	22.4	389	420	387	3.87e-08	53.9
ShaoY_2019_ERR3404634_bin.2_k119_2316_32	SARG|ZP_04648601	22.1	384	420	384	8.68e-07	49.7
ShaoY_2019_ERR3404634_bin.2_k119_2316_32	SARG|ZP_03982909	22.1	384	420	394	8.87e-07	49.7
ShaoY_2019_ERR3404634_bin.2_k119_2316_32	SARG|ZP_03948381	22.1	384	420	394	1.56e-06	48.9
ShaoY_2019_ERR3404634_bin.2_k119_2316_32	SARG|AAY21388	22.1	384	420	384	2.03e-06	48.5
ShaoY_2019_ERR3404634_bin.2_k119_2316_32	SARG|gb|BAC11911.1|ARO:3003551|emeA	30.5	82	420	393	8.46e-06	46.6
ShaoY_2019_ERR3404634_bin.2_k119_2316_38	SARG|YP_001571041	46.6	219	225	648	2.97e-64	209
ShaoY_2019_ERR3404634_bin.2_k119_2316_38	SARG|gi|960873409|ref|WP_058345546.1|	46.6	219	225	648	2.97e-64	209
ShaoY_2019_ERR3404634_bin.2_k119_2316_38	SARG|gi|446048013|ref|WP_000125868.1|	46.6	219	225	648	1.14e-63	207
ShaoY_2019_ERR3404634_bin.2_k119_2316_38	SARG|gi|555268037|ref|WP_023249477.1|	45.1	224	225	648	1.14e-63	207
ShaoY_2019_ERR3404634_bin.2_k119_2316_38	SARG|gi|696368937|ref|WP_032943949.1|	45.7	219	225	648	1.14e-63	207
ShaoY_2019_ERR3404634_bin.2_k119_2316_38	SARG|gi|851913025|ref|WP_048215946.1|	45.7	219	225	648	1.14e-63	207
ShaoY_2019_ERR3404634_bin.2_k119_2316_38	SARG|gi|489930965|ref|WP_003834285.1|	45.7	219	225	648	1.14e-63	207
ShaoY_2019_ERR3404634_bin.2_k119_2316_38	SARG|gi|740610794|ref|WP_038396317.1|	46.1	219	225	648	1.14e-63	207
ShaoY_2019_ERR3404634_bin.2_k119_2316_38	SARG|gi|924626178|ref|WP_053530123.1|	45.1	224	225	648	1.59e-63	207
ShaoY_2019_ERR3404634_bin.2_k119_2316_38	SARG|gi|851922185|ref|WP_048218206.1|	45.7	219	225	648	1.59e-63	207
ShaoY_2019_ERR3404634_bin.2_k119_2316_39	SARG|gb|AAV85982.1|ARO:3000535|macB	30.5	410	403	644	2.41e-36	139
ShaoY_2019_ERR3404634_bin.2_k119_2316_39	SARG|gi|896088003|ref|WP_049126277.1|	27.9	398	403	646	1.35e-34	134
ShaoY_2019_ERR3404634_bin.2_k119_2316_39	SARG|gi|1016949518|ref|WP_063150532.1|	27.9	398	403	646	2.49e-34	133
ShaoY_2019_ERR3404634_bin.2_k119_2316_39	SARG|gi|671541568|ref|WP_031525212.1|	27.1	398	403	648	2.52e-34	133
ShaoY_2019_ERR3404634_bin.2_k119_2316_39	SARG|gi|749017716|ref|WP_040076354.1|	27.6	398	403	646	3.39e-34	133
ShaoY_2019_ERR3404634_bin.2_k119_2316_39	SARG|gi|1028112073|ref|WP_063866263.1|	28.6	399	403	646	3.39e-34	133
ShaoY_2019_ERR3404634_bin.2_k119_2316_39	SARG|gi|1022641085|ref|WP_063404331.1|	27.9	398	403	646	3.39e-34	133
ShaoY_2019_ERR3404634_bin.2_k119_2316_39	SARG|gi|554685678|ref|WP_023185565.1|	27.5	397	403	648	3.42e-34	133
ShaoY_2019_ERR3404634_bin.2_k119_2316_39	SARG|gi|1028180030|ref|WP_063927084.1|	27.9	398	403	646	4.61e-34	132
ShaoY_2019_ERR3404634_bin.2_k119_2316_39	SARG|gi|1016932841|ref|WP_063135291.1|	27.9	398	403	646	6.26e-34	132
ShaoY_2019_ERR3404634_bin.2_k119_2370_11	SARG|gb|CAC99773.1|ARO:3003770|Listeria	40.8	841	844	865	3.15e-217	635
ShaoY_2019_ERR3404634_bin.2_k119_2370_11	megares|MEG_4053|Drugs|Cationic_antimicrobial_peptide|Defensin-resistant_mprF|MPRF_1	38.5	846	844	847	2.57e-202	596
ShaoY_2019_ERR3404634_bin.2_k119_2370_11	SARG|gb|AAN00989.1|ARO:3003774|Streptococcus	38.5	846	844	847	2.57e-202	596
ShaoY_2019_ERR3404634_bin.2_k119_2370_11	SARG|gb|CAX52582.1|ARO:3003324|Bacillus	33.0	860	844	856	4.52e-127	401
ShaoY_2019_ERR3404634_bin.2_k119_2370_11	SARG|gb|ABG86067.1|ARO:3003773|Clostridium	34.0	544	844	569	9.83e-85	280
ShaoY_2019_ERR3404634_bin.2_k119_2370_11	megares|MEG_4054|Drugs|Cationic_antimicrobial_peptide|Defensin-resistant_mprF|MPRF_1	27.7	664	844	880	1.39e-52	196
ShaoY_2019_ERR3404634_bin.2_k119_2370_11	SARG|gb|Q8FW76|ARO:3003772|Brucella	27.7	664	844	880	1.39e-52	196
ShaoY_2019_ERR3404634_bin.2_k119_2370_15	SARG|gi|502669352|ref|WP_012905216.1|	34.9	106	746	648	1.37e-07	53.9
ShaoY_2019_ERR3404634_bin.2_k119_2370_15	SARG|gi|446048013|ref|WP_000125868.1|	34.5	110	746	648	1.80e-07	53.5
ShaoY_2019_ERR3404634_bin.2_k119_2370_15	SARG|NP_286651	37.3	75	746	648	2.37e-07	53.1
ShaoY_2019_ERR3404634_bin.2_k119_2370_15	SARG|gi|968563772|ref|WP_058587854.1|	37.3	75	746	648	3.12e-07	52.8
ShaoY_2019_ERR3404634_bin.2_k119_2370_15	SARG|gi|757782629|ref|WP_043001213.1|	37.3	75	746	648	3.12e-07	52.8
ShaoY_2019_ERR3404634_bin.2_k119_2370_15	SARG|gi|446110272|ref|WP_000188127.1|	38.7	75	746	648	3.12e-07	52.8
ShaoY_2019_ERR3404634_bin.2_k119_2370_15	SARG|gi|763399392|ref|WP_044256358.1|	37.3	75	746	648	3.12e-07	52.8
ShaoY_2019_ERR3404634_bin.2_k119_2370_15	SARG|gi|992390012|ref|WP_061077002.1|	37.3	75	746	648	3.12e-07	52.8
ShaoY_2019_ERR3404634_bin.2_k119_2370_15	SARG|gi|763407609|ref|WP_044264203.1|	37.3	75	746	648	3.12e-07	52.8
ShaoY_2019_ERR3404634_bin.2_k119_2370_15	SARG|gi|754927849|ref|WP_042284850.1|	37.3	75	746	648	3.12e-07	52.8
ShaoY_2019_ERR3404634_bin.2_k119_2370_25	SARG|WP_000136147.1	52.5	396	399	399	1.15e-141	408
ShaoY_2019_ERR3404634_bin.2_k119_2370_25	CARD|gb|ABV18113.1|ARO:3001329|mdtG	48.8	391	399	408	2.90e-134	389
ShaoY_2019_ERR3404634_bin.2_k119_2370_25	NCBI|EHE72460.1|1|1|pmrA|pmrA|efflux|1|quinolone|quinolone|multidrug_efflux_MFS_transporter_PmrA|AMR|quinolone	49.7	396	399	371	2.71e-128	373
ShaoY_2019_ERR3404634_bin.2_k119_2370_25	SARG|gi|488395528|ref|WP_002464913.1|	21.1	361	399	389	2.67e-14	72.8
ShaoY_2019_ERR3404634_bin.2_k119_2370_33	CARD|gb|ATC67679.1|ARO:3000838|arlR	56.4	227	229	219	3.65e-83	246
ShaoY_2019_ERR3404634_bin.2_k119_2370_33	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	41.4	222	229	228	9.20e-50	161
ShaoY_2019_ERR3404634_bin.2_k119_2370_33	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.1	223	229	231	4.54e-45	149
ShaoY_2019_ERR3404634_bin.2_k119_2370_33	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.9	227	229	232	4.67e-45	149
ShaoY_2019_ERR3404634_bin.2_k119_2370_33	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.9	227	229	232	4.67e-45	149
ShaoY_2019_ERR3404634_bin.2_k119_2370_33	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.3	227	229	231	1.28e-44	148
ShaoY_2019_ERR3404634_bin.2_k119_2370_33	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	37.3	225	229	231	2.55e-44	147
ShaoY_2019_ERR3404634_bin.2_k119_2370_33	CARD|gb|AAG05188.1|ARO:3005068|ParR	38.8	227	229	235	8.02e-44	146
ShaoY_2019_ERR3404634_bin.2_k119_2370_33	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	37.2	223	229	231	1.43e-43	145
ShaoY_2019_ERR3404634_bin.2_k119_2370_33	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	37.2	223	229	231	5.69e-43	144
ShaoY_2019_ERR3404634_bin.2_k119_2370_34	CARD|gb|ABD30512.1|ARO:3000839|arlS	34.5	374	503	451	1.10e-64	215
ShaoY_2019_ERR3404634_bin.2_k119_2370_34	NCBI|WP_028530133.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	26.6	290	503	381	4.42e-24	102
ShaoY_2019_ERR3404634_bin.2_k119_2370_34	megares|MEG_7506|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	26.6	290	503	381	4.42e-24	102
ShaoY_2019_ERR3404634_bin.2_k119_2370_34	megares|MEG_7505|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	26.6	290	503	381	8.09e-24	102
ShaoY_2019_ERR3404634_bin.2_k119_2370_34	NCBI|WP_063856730.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	26.6	290	503	381	8.09e-24	102
ShaoY_2019_ERR3404634_bin.2_k119_2370_34	CARD|gb|ADM92606.1|ARO:3000549|adeS	29.5	275	503	361	8.49e-24	101
ShaoY_2019_ERR3404634_bin.2_k119_2370_34	NCBI|WP_063856744.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.0	218	503	381	3.66e-23	100
ShaoY_2019_ERR3404634_bin.2_k119_2370_34	megares|MEG_7504|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.0	218	503	381	3.66e-23	100
ShaoY_2019_ERR3404634_bin.2_k119_2370_34	megares|MEG_7507|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	25.9	290	503	381	1.22e-22	98.6
ShaoY_2019_ERR3404634_bin.2_k119_2370_34	NCBI|WP_063856738.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	25.9	290	503	381	1.22e-22	98.6
ShaoY_2019_ERR3404634_bin.2_k119_2398_1	SARG|gb|ASE57902.1|ARO:3003731|fusD	40.8	213	216	213	7.05e-56	176
ShaoY_2019_ERR3404634_bin.2_k119_2398_1	SARG|AAL12234	40.1	212	216	213	1.48e-52	167
ShaoY_2019_ERR3404634_bin.2_k119_2398_1	SARG|CAJ43426	40.4	208	216	210	3.83e-52	166
ShaoY_2019_ERR3404634_bin.2_k119_2398_1	SARG|gi|1028094217|ref|WP_063851255.1|	39.6	212	216	213	8.40e-52	165
ShaoY_2019_ERR3404634_bin.2_k119_2398_1	SARG|gb|CAG41812.1|ARO:3003733|fusC	38.6	210	216	212	1.10e-43	144
ShaoY_2019_ERR3404634_bin.2_k119_2398_12	megares|MEG_1289|Drugs|beta-lactam|Penicillin_binding_protein_regulator|BLAI_1	36.4	118	147	126	5.37e-23	86.7
ShaoY_2019_ERR3404634_bin.2_k119_2398_20	SARG|gi|639242619|ref|WP_024572769.1|	54.3	105	112	112	1.55e-33	111
ShaoY_2019_ERR3404634_bin.2_k119_2398_20	SARG|gi|503879533|ref|WP_014113527.1|	51.4	105	112	112	2.20e-33	111
ShaoY_2019_ERR3404634_bin.2_k119_2398_20	SARG|gi|505196367|ref|WP_015383469.1|	54.3	105	112	112	2.20e-33	111
ShaoY_2019_ERR3404634_bin.2_k119_2398_20	SARG|gi|489311090|ref|WP_003218499.1|	50.5	105	112	112	4.43e-33	110
ShaoY_2019_ERR3404634_bin.2_k119_2398_20	SARG|gi|504292487|ref|WP_014479589.1|	54.3	105	112	112	4.43e-33	110
ShaoY_2019_ERR3404634_bin.2_k119_2398_20	SARG|gi|489331808|ref|WP_003239065.1|	50.5	105	112	112	6.29e-33	110
ShaoY_2019_ERR3404634_bin.2_k119_2398_20	SARG|P49856	53.3	105	112	112	6.29e-33	110
ShaoY_2019_ERR3404634_bin.2_k119_2398_20	SARG|gi|740643397|ref|WP_038428846.1|	52.4	105	112	112	2.55e-32	108
ShaoY_2019_ERR3404634_bin.2_k119_2398_20	SARG|gi|489421662|ref|WP_003327390.1|	50.5	105	112	112	5.93e-31	105
ShaoY_2019_ERR3404634_bin.2_k119_2398_20	SARG|gi|505052607|ref|WP_015239709.1|	50.0	104	112	112	1.38e-29	101
ShaoY_2019_ERR3404634_bin.2_k119_2398_21	SARG|gi|320021335|gb|ADV96321.1|	46.2	104	104	105	4.80e-29	99.8
ShaoY_2019_ERR3404634_bin.2_k119_2398_21	SARG|gi|291483835|dbj|BAI84910.1|	46.2	104	104	105	6.82e-29	99.4
ShaoY_2019_ERR3404634_bin.2_k119_2398_21	SARG|gi|489311091|ref|WP_003218500.1|	46.2	104	104	105	9.67e-29	99.0
ShaoY_2019_ERR3404634_bin.2_k119_2398_21	SARG|P49857	46.2	104	104	105	1.37e-28	98.6
ShaoY_2019_ERR3404634_bin.2_k119_2398_21	SARG|gi|489421661|ref|WP_003327389.1|	48.5	103	104	105	3.92e-28	97.4
ShaoY_2019_ERR3404634_bin.2_k119_2398_21	SARG|gi|489246601|ref|WP_003154765.1|	45.2	104	104	104	1.26e-26	93.6
ShaoY_2019_ERR3404634_bin.2_k119_2398_21	SARG|ABS73654	45.2	104	104	104	2.53e-26	92.8
ShaoY_2019_ERR3404634_bin.2_k119_2398_21	SARG|gi|515503150|ref|WP_016936404.1|	45.2	104	104	104	1.02e-25	91.3
ShaoY_2019_ERR3404634_bin.2_k119_2398_21	SARG|gb|AAG08375.1|ARO:3004038|Pseudomonas	33.7	101	104	110	1.44e-10	52.8
ShaoY_2019_ERR3404634_bin.2_k119_2398_21	SARG|gb|AEH26330.1|ARO:3005009|qacE	32.0	103	104	110	4.02e-10	51.6
ShaoY_2019_ERR3404634_bin.2_k119_2398_31	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	41.3	235	231	233	1.18e-57	181
ShaoY_2019_ERR3404634_bin.2_k119_2398_31	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	40.1	232	231	232	4.61e-57	180
ShaoY_2019_ERR3404634_bin.2_k119_2398_31	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	40.3	226	231	231	6.33e-57	179
ShaoY_2019_ERR3404634_bin.2_k119_2398_31	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	40.2	229	231	232	1.31e-56	179
ShaoY_2019_ERR3404634_bin.2_k119_2398_31	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	40.5	227	231	232	2.97e-55	175
ShaoY_2019_ERR3404634_bin.2_k119_2398_31	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.6	228	231	231	1.05e-52	169
ShaoY_2019_ERR3404634_bin.2_k119_2398_31	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.6	235	231	231	1.05e-52	169
ShaoY_2019_ERR3404634_bin.2_k119_2398_31	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.6	235	231	231	1.49e-52	168
ShaoY_2019_ERR3404634_bin.2_k119_2398_31	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	39.0	228	231	231	2.10e-52	168
ShaoY_2019_ERR3404634_bin.2_k119_2398_31	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.6	235	231	231	2.97e-52	167
ShaoY_2019_ERR3404634_bin.2_k119_2398_32	NCBI|WP_063856732.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	32.1	215	494	367	1.34e-31	124
ShaoY_2019_ERR3404634_bin.2_k119_2398_32	NCBI|WP_021418927.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	32.1	215	494	368	1.36e-31	124
ShaoY_2019_ERR3404634_bin.2_k119_2398_32	NCBI|WP_063856744.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	30.0	230	494	381	2.09e-30	120
ShaoY_2019_ERR3404634_bin.2_k119_2398_32	megares|MEG_7504|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	30.0	230	494	381	2.09e-30	120
ShaoY_2019_ERR3404634_bin.2_k119_2398_32	NCBI|AXB64455.1|1|1|vanS-Cd|vanS-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|VanG-Cd-type_glycopeptide_resistance_histidine_kinase_VanS|AMR|glycopeptide	30.4	260	494	380	3.86e-30	120
ShaoY_2019_ERR3404634_bin.2_k119_2398_32	megares|MEG_7498|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	30.4	260	494	380	3.86e-30	120
ShaoY_2019_ERR3404634_bin.2_k119_2398_32	megares|MEG_7521|Drugs|Glycopeptide|VanN-type_regulator|VANSN_1	30.2	265	494	364	4.06e-30	119
ShaoY_2019_ERR3404634_bin.2_k119_2398_32	NCBI|WP_063856749.1|1|1|vanS-N|vanS-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-N|AMR|glycopeptide	30.2	265	494	364	4.06e-30	119
ShaoY_2019_ERR3404634_bin.2_k119_2398_32	NCBI|WP_011461302.1|1|1|vanS-I|vanS-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-I|AMR|glycopeptide	28.8	267	494	392	1.18e-29	119
ShaoY_2019_ERR3404634_bin.2_k119_2398_32	megares|MEG_7514|Drugs|Glycopeptide|VanL-type_regulator|VANSL_1	29.5	264	494	364	1.42e-29	118
ShaoY_2019_ERR3404634_bin.2_k119_2398_71	SARG|gi|495736522|ref|WP_008461101.1|	48.6	220	237	648	3.14e-65	212
ShaoY_2019_ERR3404634_bin.2_k119_2398_71	SARG|gi|746253210|ref|WP_039301529.1|	48.6	220	237	648	3.14e-65	212
ShaoY_2019_ERR3404634_bin.2_k119_2398_71	SARG|gi|696402390|ref|WP_032974230.1|	47.7	220	237	647	8.43e-65	211
ShaoY_2019_ERR3404634_bin.2_k119_2398_71	SARG|gi|696423952|ref|WP_032993748.1|	47.7	220	237	647	8.43e-65	211
ShaoY_2019_ERR3404634_bin.2_k119_2398_71	SARG|gi|495004199|ref|WP_007730213.1|	48.2	220	237	647	1.18e-64	211
ShaoY_2019_ERR3404634_bin.2_k119_2398_71	SARG|gi|742409107|ref|WP_038888226.1|	48.2	220	237	647	1.18e-64	211
ShaoY_2019_ERR3404634_bin.2_k119_2398_71	SARG|gi|506220920|ref|WP_015740695.1|	47.3	220	237	647	1.65e-64	210
ShaoY_2019_ERR3404634_bin.2_k119_2398_71	SARG|gi|746243059|ref|WP_039291473.1|	48.6	220	237	648	1.68e-64	210
ShaoY_2019_ERR3404634_bin.2_k119_2398_71	SARG|gi|736472622|ref|WP_034494292.1|	49.1	220	237	648	1.68e-64	210
ShaoY_2019_ERR3404634_bin.2_k119_2398_71	SARG|gi|742378414|ref|WP_038857601.1|	47.3	220	237	647	2.30e-64	210
ShaoY_2019_ERR3404634_bin.2_k119_2398_72	SARG|YP_001571041	30.9	414	410	648	1.13e-36	140
ShaoY_2019_ERR3404634_bin.2_k119_2398_72	SARG|gi|960873409|ref|WP_058345546.1|	30.9	414	410	648	1.13e-36	140
ShaoY_2019_ERR3404634_bin.2_k119_2398_72	SARG|gi|740610794|ref|WP_038396317.1|	30.9	414	410	648	1.13e-36	140
ShaoY_2019_ERR3404634_bin.2_k119_2398_72	SARG|gi|446048013|ref|WP_000125868.1|	30.3	416	410	648	5.28e-36	138
ShaoY_2019_ERR3404634_bin.2_k119_2398_72	SARG|gi|555268037|ref|WP_023249477.1|	30.3	406	410	648	9.79e-36	137
ShaoY_2019_ERR3404634_bin.2_k119_2398_72	SARG|gi|983413012|ref|WP_060578893.1|	30.6	409	410	646	1.32e-35	137
ShaoY_2019_ERR3404634_bin.2_k119_2398_72	SARG|gi|835330218|ref|WP_047457825.1|	30.8	412	410	648	1.33e-35	137
ShaoY_2019_ERR3404634_bin.2_k119_2398_72	SARG|gi|924626178|ref|WP_053530123.1|	30.3	406	410	648	1.33e-35	137
ShaoY_2019_ERR3404634_bin.2_k119_2398_72	SARG|gi|694073280|ref|WP_032419142.1|	30.6	409	410	646	1.80e-35	137
ShaoY_2019_ERR3404634_bin.2_k119_2398_72	SARG|gi|1044175355|emb|SBY84545.1|	31.1	409	410	646	1.80e-35	137
ShaoY_2019_ERR3404634_bin.2_k119_2398_74	SARG|AE016830.1.gene424.p01	99.4	491	492	505	0.0	927
ShaoY_2019_ERR3404634_bin.2_k119_2398_74	SARG|NC_002951.3237948.p01	44.1	508	492	643	1.42e-133	399
ShaoY_2019_ERR3404634_bin.2_k119_2398_74	SARG|NC_002951.3238155.p01	42.9	457	492	465	2.64e-123	367
ShaoY_2019_ERR3404634_bin.2_k119_2398_74	SARG|NC_002951.3237419.p01	43.9	424	492	480	1.37e-118	355
ShaoY_2019_ERR3404634_bin.2_k119_2398_74	SARG|NC_009641.5331418.p01	42.3	444	492	452	3.22e-118	353
ShaoY_2019_ERR3404634_bin.2_k119_2398_74	SARG|gi|1044618389|gb|OCB92939.1|	41.8	481	492	477	2.53e-112	339
ShaoY_2019_ERR3404634_bin.2_k119_2398_74	SARG|gi|1007411670|gb|AMQ72759.1|	41.8	481	492	477	3.57e-112	339
ShaoY_2019_ERR3404634_bin.2_k119_2398_74	SARG|gi|1030030526|gb|ANF35167.1|	41.2	481	492	477	1.01e-111	338
ShaoY_2019_ERR3404634_bin.2_k119_2398_74	SARG|gi|393806119|gb|EJD67473.1|	41.6	481	492	477	1.01e-111	338
ShaoY_2019_ERR3404634_bin.2_k119_2398_74	SARG|gi|631799622|gb|AHZ14287.1|	41.0	480	492	477	1.42e-111	337
ShaoY_2019_ERR3404634_bin.2_k119_2719_9	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	30.9	837	927	1024	1.03e-112	369
ShaoY_2019_ERR3404634_bin.2_k119_2719_9	SARG|gb|CAA53189|ARO:3000521|mupA	30.9	837	927	1024	1.03e-112	369
ShaoY_2019_ERR3404634_bin.2_k119_2719_9	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	30.9	837	927	1024	1.43e-112	369
ShaoY_2019_ERR3404634_bin.2_k119_2719_9	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	30.9	837	927	1024	1.43e-112	369
ShaoY_2019_ERR3404634_bin.2_k119_2719_9	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	31.2	786	927	1033	8.53e-109	359
ShaoY_2019_ERR3404634_bin.2_k119_2719_9	SARG|gb|AEY83581|ARO:3000510|mupB	31.2	786	927	1033	8.53e-109	359
ShaoY_2019_ERR3404634_bin.2_k119_2719_19	megares|MEG_7572|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	24.9	341	457	481	8.88e-07	50.1
ShaoY_2019_ERR3404634_bin.2_k119_2719_19	megares|MEG_7571|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	25.4	342	457	451	1.49e-06	49.3
ShaoY_2019_ERR3404634_bin.2_k119_2719_21	ResF|penA_1_AF515059_1	26.1	575	743	581	1.34e-44	168
ShaoY_2019_ERR3404634_bin.2_k119_2772_21	SARG|AUI09862.1	38.1	278	264	287	9.02e-47	156
ShaoY_2019_ERR3404634_bin.2_k119_2772_21	SARG|AJ459418.gene.p01	35.2	264	264	263	1.41e-42	145
ShaoY_2019_ERR3404634_bin.2_k119_2772_21	SARG|gi|970263436|ref|WP_058647620.1|	35.2	264	264	263	1.98e-42	144
ShaoY_2019_ERR3404634_bin.2_k119_2906_8	SARG|gi|507050365|ref|WP_016121371.1|	29.3	225	318	309	4.26e-31	117
ShaoY_2019_ERR3404634_bin.2_k119_2906_8	SARG|gi|500448961|gb|EOP61695.1|	30.2	225	318	306	2.94e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_2906_8	SARG|gi|500465078|gb|EOP76697.1|	30.7	225	318	306	7.90e-29	111
ShaoY_2019_ERR3404634_bin.2_k119_2906_8	SARG|gi|694064328|ref|WP_032410816.1|	33.7	205	318	646	1.64e-21	94.0
ShaoY_2019_ERR3404634_bin.2_k119_2906_8	SARG|gb|WP_082039181.1|ARO:3007028|salD	27.6	181	318	544	2.01e-10	60.5
ShaoY_2019_ERR3404634_bin.2_k119_2906_22	SARG|gb|AAK76137.1|ARO:3000024|patA	28.7	230	246	564	2.49e-17	79.7
ShaoY_2019_ERR3404634_bin.2_k119_2906_22	SARG|gb|APB03219.1|ARO:3003986|TaeA	28.3	272	246	648	1.06e-11	63.2
ShaoY_2019_ERR3404634_bin.2_k119_2906_22	SARG|gi|895819918|ref|WP_048943810.1|	28.6	206	246	498	3.85e-08	52.4
ShaoY_2019_ERR3404634_bin.2_k119_2906_22	SARG|gi|498521217|ref|WP_010821069.1|	28.6	206	246	498	3.85e-08	52.4
ShaoY_2019_ERR3404634_bin.2_k119_2906_22	SARG|gi|488324747|ref|WP_002394132.1|	28.6	206	246	498	3.85e-08	52.4
ShaoY_2019_ERR3404634_bin.2_k119_2906_22	SARG|gi|488328493|ref|WP_002397878.1|	28.6	206	246	498	3.85e-08	52.4
ShaoY_2019_ERR3404634_bin.2_k119_2906_22	SARG|gi|514883218|ref|WP_016615053.1|	29.1	206	246	498	5.17e-08	52.0
ShaoY_2019_ERR3404634_bin.2_k119_2906_22	SARG|gi|488303094|ref|WP_002374069.1|	29.1	206	246	498	5.17e-08	52.0
ShaoY_2019_ERR3404634_bin.2_k119_2906_22	SARG|gi|514904648|ref|WP_016630030.1|	28.2	206	246	498	5.17e-08	52.0
ShaoY_2019_ERR3404634_bin.2_k119_2906_22	SARG|gi|727118387|ref|WP_033626720.1|	29.1	206	246	498	6.94e-08	51.6
ShaoY_2019_ERR3404634_bin.2_k119_2906_24	megares|MEG_1060|Drugs|Aminoglycosides|Aminoglycoside_O-phosphotransferases|APH3-PRIME_1	40.3	236	260	266	8.05e-63	197
ShaoY_2019_ERR3404634_bin.2_k119_2906_25	NCBI|WP_231869586.1|1|1|npmB1|npmB||2|aminoglycoside|aminoglycoside|16S_rRNA_(adenine(1408)-N(1))-methyltransferase_NpmB1|AMR|aminoglycoside	26.4	140	215	217	9.65e-06	43.9
ShaoY_2019_ERR3404634_bin.2_k119_2906_35	SARG|NP_348076	30.0	454	525	652	1.09e-43	163
ShaoY_2019_ERR3404634_bin.2_k119_2906_35	SARG|L42544.gene.p01	27.9	448	525	651	5.13e-43	161
ShaoY_2019_ERR3404634_bin.2_k119_2906_35	SARG|AAV80410	27.9	448	525	651	5.13e-43	161
ShaoY_2019_ERR3404634_bin.2_k119_2906_35	SARG|ABB70053	26.5	449	525	639	9.02e-41	154
ShaoY_2019_ERR3404634_bin.2_k119_2906_35	SARG|ABB70047	26.5	449	525	639	9.02e-41	154
ShaoY_2019_ERR3404634_bin.2_k119_2906_35	SARG|ZP_02952732	26.1	449	525	652	1.37e-40	154
ShaoY_2019_ERR3404634_bin.2_k119_2906_35	SARG|ZP_02632674	26.1	449	525	660	1.46e-40	154
ShaoY_2019_ERR3404634_bin.2_k119_2906_35	SARG|ABW24731	26.7	449	525	639	1.67e-40	154
ShaoY_2019_ERR3404634_bin.2_k119_2906_35	SARG|CAJ00301	26.3	449	525	639	1.67e-40	154
ShaoY_2019_ERR3404634_bin.2_k119_2906_35	SARG|CAL69903	26.5	449	525	639	1.67e-40	154
ShaoY_2019_ERR3404634_bin.2_k119_3040_19	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	28.3	212	569	504	1.66e-14	75.1
ShaoY_2019_ERR3404634_bin.2_k119_3040_19	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	26.5	211	569	505	2.20e-14	74.7
ShaoY_2019_ERR3404634_bin.2_k119_3040_26	SARG|gi|500194536|ref|WP_011867743.1|	29.5	281	357	306	4.60e-29	113
ShaoY_2019_ERR3404634_bin.2_k119_3040_26	SARG|gb|AHB37625.1|ARO:3004715|vga(E)	25.4	205	357	524	1.97e-08	54.7
ShaoY_2019_ERR3404634_bin.2_k119_3040_30	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.3	501	513	655	8.67e-72	239
ShaoY_2019_ERR3404634_bin.2_k119_3040_30	SARG|gb|AKA86814|ARO:3003746|optrA	30.3	501	513	655	8.67e-72	239
ShaoY_2019_ERR3404634_bin.2_k119_3040_30	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.3	501	513	655	1.21e-71	239
ShaoY_2019_ERR3404634_bin.2_k119_3040_30	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.3	501	513	655	1.21e-71	239
ShaoY_2019_ERR3404634_bin.2_k119_3040_30	megares|MEG_4321|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.3	501	513	655	1.69e-71	239
ShaoY_2019_ERR3404634_bin.2_k119_3040_30	megares|MEG_4317|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.3	501	513	655	1.69e-71	239
ShaoY_2019_ERR3404634_bin.2_k119_3040_30	megares|MEG_4314|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.3	501	513	655	1.69e-71	239
ShaoY_2019_ERR3404634_bin.2_k119_3040_30	megares|MEG_4323|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.3	501	513	655	1.69e-71	239
ShaoY_2019_ERR3404634_bin.2_k119_3040_30	megares|MEG_4319|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.3	501	513	655	1.69e-71	239
ShaoY_2019_ERR3404634_bin.2_k119_3040_30	megares|MEG_4311|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.3	501	513	655	1.69e-71	239
ShaoY_2019_ERR3404634_bin.2_k119_3040_33	SARG|gi|817122037|ref|WP_046494699.1|	28.0	225	250	613	3.67e-11	61.6
ShaoY_2019_ERR3404634_bin.2_k119_3040_33	SARG|gi|860594225|ref|WP_048475168.1|	28.7	223	250	620	1.21e-10	60.1
ShaoY_2019_ERR3404634_bin.2_k119_3040_33	SARG|gi|496018010|ref|WP_008742581.1|	29.1	223	250	623	2.19e-10	59.3
ShaoY_2019_ERR3404634_bin.2_k119_3040_33	SARG|gi|648667297|ref|WP_026359044.1|	27.2	246	250	605	2.91e-10	58.9
ShaoY_2019_ERR3404634_bin.2_k119_3040_33	SARG|AF170880.4.gene1.p01	27.2	224	250	615	5.29e-10	58.2
ShaoY_2019_ERR3404634_bin.2_k119_3040_33	SARG|gi|926400371|ref|WP_053728483.1|	28.7	216	250	603	7.06e-10	57.8
ShaoY_2019_ERR3404634_bin.2_k119_3040_33	SARG|gi|663350985|ref|WP_030349761.1|	27.4	234	250	613	7.10e-10	57.8
ShaoY_2019_ERR3404634_bin.2_k119_3040_33	SARG|gi|558888514|ref|WP_023543283.1|	27.2	224	250	615	9.56e-10	57.4
ShaoY_2019_ERR3404634_bin.2_k119_3040_33	SARG|gi|662754041|ref|WP_030125200.1|	26.6	248	250	601	1.27e-09	57.0
ShaoY_2019_ERR3404634_bin.2_k119_3040_33	SARG|gi|664100597|ref|WP_030638327.1|	26.6	248	250	601	1.27e-09	57.0
ShaoY_2019_ERR3404634_bin.2_k119_3040_38	CARD|gb|ABV18113.1|ARO:3001329|mdtG	51.6	382	413	408	9.05e-137	396
ShaoY_2019_ERR3404634_bin.2_k119_3040_38	SARG|WP_000136147.1	41.1	382	413	399	8.09e-101	304
ShaoY_2019_ERR3404634_bin.2_k119_3040_38	NCBI|EHE72460.1|1|1|pmrA|pmrA|efflux|1|quinolone|quinolone|multidrug_efflux_MFS_transporter_PmrA|AMR|quinolone	38.5	382	413	371	5.05e-89	273
ShaoY_2019_ERR3404634_bin.2_k119_3040_43	megares|MEG_7070|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETD_1	32.3	96	288	138	7.43e-12	60.8
ShaoY_2019_ERR3404634_bin.2_k119_3040_46	SARG|gi|817122037|ref|WP_046494699.1|	32.9	234	578	613	2.63e-33	133
ShaoY_2019_ERR3404634_bin.2_k119_3040_46	SARG|gi|505420018|ref|WP_015607120.1|	31.8	233	578	603	1.09e-32	131
ShaoY_2019_ERR3404634_bin.2_k119_3040_46	SARG|AF170880.4.gene1.p01	32.2	233	578	615	1.17e-32	131
ShaoY_2019_ERR3404634_bin.2_k119_3040_46	SARG|gi|695842130|ref|WP_032755430.1|	31.8	233	578	603	1.46e-32	131
ShaoY_2019_ERR3404634_bin.2_k119_3040_46	SARG|gi|695865802|ref|WP_032778631.1|	31.8	233	578	605	2.00e-32	130
ShaoY_2019_ERR3404634_bin.2_k119_3040_46	SARG|gi|663350985|ref|WP_030349761.1|	32.6	233	578	613	2.82e-32	130
ShaoY_2019_ERR3404634_bin.2_k119_3040_46	SARG|gi|558888514|ref|WP_023543283.1|	31.8	233	578	615	2.86e-32	130
ShaoY_2019_ERR3404634_bin.2_k119_3040_46	SARG|gi|764446018|ref|WP_044369325.1|	31.3	233	578	605	3.61e-32	130
ShaoY_2019_ERR3404634_bin.2_k119_3040_46	SARG|gi|917203192|ref|WP_051809904.1|	30.5	272	578	620	3.95e-32	130
ShaoY_2019_ERR3404634_bin.2_k119_3040_46	SARG|gi|860594225|ref|WP_048475168.1|	31.5	257	578	620	3.95e-32	130
ShaoY_2019_ERR3404634_bin.2_k119_3040_47	SARG|gi|695887424|ref|WP_032788534.1|	29.1	512	588	605	3.79e-51	184
ShaoY_2019_ERR3404634_bin.2_k119_3040_47	SARG|gi|695865802|ref|WP_032778631.1|	28.9	512	588	605	9.87e-51	183
ShaoY_2019_ERR3404634_bin.2_k119_3040_47	SARG|gi|764446018|ref|WP_044369325.1|	28.5	515	588	605	2.57e-50	182
ShaoY_2019_ERR3404634_bin.2_k119_3040_47	SARG|gi|664180077|ref|WP_030714054.1|	28.9	512	588	605	2.57e-50	182
ShaoY_2019_ERR3404634_bin.2_k119_3040_47	SARG|gi|497748188|ref|WP_010062372.1|	28.9	512	588	605	3.53e-50	182
ShaoY_2019_ERR3404634_bin.2_k119_3040_47	SARG|gi|1045390184|ref|WP_065479071.1|	28.2	515	588	605	3.53e-50	182
ShaoY_2019_ERR3404634_bin.2_k119_3040_47	SARG|gi|664170108|ref|WP_030704355.1|	28.6	514	588	603	2.31e-49	179
ShaoY_2019_ERR3404634_bin.2_k119_3040_47	SARG|AF170880.4.gene1.p01	27.9	513	588	615	2.74e-49	179
ShaoY_2019_ERR3404634_bin.2_k119_3040_47	SARG|gi|490068471|ref|WP_003970646.1|	28.6	514	588	603	3.18e-49	179
ShaoY_2019_ERR3404634_bin.2_k119_3040_47	SARG|gi|947982677|ref|WP_056642336.1|	28.4	522	588	626	3.18e-49	179
ShaoY_2019_ERR3404634_bin.2_k119_3515_7	SARG|gb|CAE00499.1|ARO:3003835|cdeA	31.5	441	447	441	2.02e-65	215
ShaoY_2019_ERR3404634_bin.2_k119_3515_7	SARG|ZP_04679156	26.3	422	447	451	2.74e-27	112
ShaoY_2019_ERR3404634_bin.2_k119_3515_7	SARG|gi|488374619|ref|WP_002444004.1|	24.5	420	447	452	1.28e-26	110
ShaoY_2019_ERR3404634_bin.2_k119_3515_7	SARG|gi|446573718|ref|WP_000651064.1|	28.0	411	447	451	5.83e-26	108
ShaoY_2019_ERR3404634_bin.2_k119_3515_7	SARG|gi|686155635|ref|WP_031787393.1|	27.7	411	447	451	1.97e-25	107
ShaoY_2019_ERR3404634_bin.2_k119_3515_7	SARG|gi|686172137|ref|WP_031795999.1|	26.6	398	447	451	8.97e-25	105
ShaoY_2019_ERR3404634_bin.2_k119_3515_7	SARG|YP_302230	24.1	395	447	451	1.64e-24	104
ShaoY_2019_ERR3404634_bin.2_k119_3515_7	SARG|gi|446573715|ref|WP_000651061.1|	27.3	395	447	451	1.64e-24	104
ShaoY_2019_ERR3404634_bin.2_k119_3515_7	SARG|gi|686448604|ref|WP_031928572.1|	27.6	398	447	451	1.64e-24	104
ShaoY_2019_ERR3404634_bin.2_k119_3515_7	SARG|gi|565830932|ref|WP_023914633.1|	27.3	399	447	451	3.00e-24	103
ShaoY_2019_ERR3404634_bin.2_k119_3917_17	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	25.7	257	406	307	2.50e-18	84.0
ShaoY_2019_ERR3404634_bin.2_k119_3917_17	SARG|gi|445996719|ref|WP_000074574.1|	26.7	202	406	309	1.17e-17	82.0
ShaoY_2019_ERR3404634_bin.2_k119_3917_17	SARG|gi|445996710|ref|WP_000074565.1|	26.7	202	406	309	1.17e-17	82.0
ShaoY_2019_ERR3404634_bin.2_k119_3917_17	SARG|gi|446026113|ref|WP_000103968.1|	27.9	201	406	306	2.07e-17	81.3
ShaoY_2019_ERR3404634_bin.2_k119_3917_17	SARG|P42332	27.6	199	406	306	1.28e-16	79.0
ShaoY_2019_ERR3404634_bin.2_k119_3917_17	SARG|ABB80128	27.6	199	406	306	1.28e-16	79.0
ShaoY_2019_ERR3404634_bin.2_k119_3917_17	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	27.6	199	406	306	1.28e-16	79.0
ShaoY_2019_ERR3404634_bin.2_k119_3917_17	SARG|gi|510143239|gb|AGN36970.1|	27.6	199	406	313	1.38e-16	79.0
ShaoY_2019_ERR3404634_bin.2_k119_3917_17	SARG|gi|507044560|ref|WP_016115614.1|	27.4	201	406	306	2.33e-16	78.2
ShaoY_2019_ERR3404634_bin.2_k119_3917_17	SARG|gi|500448961|gb|EOP61695.1|	25.6	207	406	306	4.26e-16	77.4
ShaoY_2019_ERR3404634_bin.2_k119_4075_8	SARG|gb|AHB37625.1|ARO:3004715|vga(E)	27.8	227	231	524	3.59e-16	75.9
ShaoY_2019_ERR3404634_bin.2_k119_4075_8	SARG|FR772051.1.gene9.p01	26.4	227	231	524	3.00e-15	73.2
ShaoY_2019_ERR3404634_bin.2_k119_4075_8	SARG|AAG08983	24.4	213	231	524	1.12e-13	68.6
ShaoY_2019_ERR3404634_bin.2_k119_4075_8	SARG|gi|488349878|ref|WP_002419263.1|	26.8	209	231	498	9.99e-12	62.8
ShaoY_2019_ERR3404634_bin.2_k119_4075_8	SARG|gi|498528849|ref|WP_010828356.1|	26.3	209	231	498	9.99e-12	62.8
ShaoY_2019_ERR3404634_bin.2_k119_4075_8	SARG|gi|881017353|ref|WP_048737885.1|	26.8	209	231	498	9.99e-12	62.8
ShaoY_2019_ERR3404634_bin.2_k119_4075_8	SARG|gi|1046366091|gb|OCK16447.1|	26.8	209	231	498	9.99e-12	62.8
ShaoY_2019_ERR3404634_bin.2_k119_4075_8	SARG|gi|498520345|ref|WP_010820225.1|	26.8	209	231	498	9.99e-12	62.8
ShaoY_2019_ERR3404634_bin.2_k119_4075_8	SARG|ZP_04437889	26.8	209	231	498	9.99e-12	62.8
ShaoY_2019_ERR3404634_bin.2_k119_4075_8	SARG|ZP_04646474	26.8	209	231	498	9.99e-12	62.8
ShaoY_2019_ERR3404634_bin.2_k119_4075_29	SARG|gb|CAC99773.1|ARO:3003770|Listeria	39.2	852	864	865	1.14e-192	572
ShaoY_2019_ERR3404634_bin.2_k119_4075_29	megares|MEG_4053|Drugs|Cationic_antimicrobial_peptide|Defensin-resistant_mprF|MPRF_1	28.5	831	864	847	3.93e-98	324
ShaoY_2019_ERR3404634_bin.2_k119_4075_29	SARG|gb|AAN00989.1|ARO:3003774|Streptococcus	28.5	831	864	847	3.93e-98	324
ShaoY_2019_ERR3404634_bin.2_k119_4075_29	SARG|gb|CAX52582.1|ARO:3003324|Bacillus	28.4	867	864	856	3.97e-72	253
ShaoY_2019_ERR3404634_bin.2_k119_4075_42	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.3	530	544	655	5.40e-68	230
ShaoY_2019_ERR3404634_bin.2_k119_4075_42	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.3	530	544	655	7.51e-68	230
ShaoY_2019_ERR3404634_bin.2_k119_4075_42	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.1	530	544	655	7.51e-68	230
ShaoY_2019_ERR3404634_bin.2_k119_4075_42	SARG|gb|AKA86814|ARO:3003746|optrA	28.1	530	544	655	7.51e-68	230
ShaoY_2019_ERR3404634_bin.2_k119_4075_42	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.5	530	544	655	1.45e-67	229
ShaoY_2019_ERR3404634_bin.2_k119_4075_42	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.1	530	544	655	2.02e-67	229
ShaoY_2019_ERR3404634_bin.2_k119_4075_42	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.1	530	544	655	2.02e-67	229
ShaoY_2019_ERR3404634_bin.2_k119_4075_42	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.1	530	544	655	2.02e-67	229
ShaoY_2019_ERR3404634_bin.2_k119_4075_42	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.1	530	544	655	2.02e-67	229
ShaoY_2019_ERR3404634_bin.2_k119_4075_42	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.1	530	544	655	2.81e-67	228
ShaoY_2019_ERR3404634_bin.2_k119_4075_52	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	43.7	682	650	703	9.26e-175	513
ShaoY_2019_ERR3404634_bin.2_k119_4075_61	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	33.1	236	241	233	2.48e-35	124
ShaoY_2019_ERR3404634_bin.2_k119_4075_61	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	33.5	233	241	235	5.16e-35	124
ShaoY_2019_ERR3404634_bin.2_k119_4075_61	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	32.0	228	241	231	7.17e-34	120
ShaoY_2019_ERR3404634_bin.2_k119_4075_61	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	31.3	227	241	231	2.80e-33	119
ShaoY_2019_ERR3404634_bin.2_k119_4075_61	NCBI|WP_063856722.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	35.5	234	241	232	5.68e-33	118
ShaoY_2019_ERR3404634_bin.2_k119_4075_61	NCBI|WP_063856727.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	35.5	234	241	232	2.22e-32	117
ShaoY_2019_ERR3404634_bin.2_k119_4075_61	NCBI|WP_063856715.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	35.5	234	241	232	2.22e-32	117
ShaoY_2019_ERR3404634_bin.2_k119_4075_61	NCBI|WP_023042613.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	35.5	234	241	232	3.12e-32	116
ShaoY_2019_ERR3404634_bin.2_k119_4075_61	NCBI|WP_016295750.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	35.5	234	241	232	3.12e-32	116
ShaoY_2019_ERR3404634_bin.2_k119_4075_61	NCBI|WP_023043165.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	35.5	234	241	232	6.16e-32	115
ShaoY_2019_ERR3404634_bin.2_k119_4238_46	SARG|AE016830.1.gene1786.p01	99.8	462	463	469	0.0	873
ShaoY_2019_ERR3404634_bin.2_k119_4238_46	SARG|YP_002188856	31.4	414	463	537	1.36e-53	187
ShaoY_2019_ERR3404634_bin.2_k119_4238_46	SARG|gi|488380213|ref|WP_002449598.1|	31.2	398	463	514	8.71e-48	171
ShaoY_2019_ERR3404634_bin.2_k119_4238_46	SARG|gi|727755142|ref|WP_033862510.1|	31.4	398	463	514	1.21e-47	170
ShaoY_2019_ERR3404634_bin.2_k119_4238_46	SARG|AAK38457	31.2	398	463	514	2.32e-47	169
ShaoY_2019_ERR3404634_bin.2_k119_4238_46	SARG|gi|3327943|gb|AAC38780.1|	31.2	398	463	514	2.32e-47	169
ShaoY_2019_ERR3404634_bin.2_k119_4238_46	SARG|gi|446545432|ref|WP_000622778.1|	30.9	398	463	514	3.21e-47	169
ShaoY_2019_ERR3404634_bin.2_k119_4238_46	SARG|AAQ10697	31.2	398	463	514	6.16e-47	168
ShaoY_2019_ERR3404634_bin.2_k119_4238_46	SARG|YP_536864	30.9	398	463	514	1.18e-46	167
ShaoY_2019_ERR3404634_bin.2_k119_4238_46	SARG|gb|BAJ09383.1|ARO:3003046|qacA	30.9	398	463	514	1.64e-46	167
ShaoY_2019_ERR3404634_bin.2_k119_4238_61	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	30.5	141	302	397	1.17e-13	69.7
ShaoY_2019_ERR3404634_bin.2_k119_4238_95	SARG|gi|694064328|ref|WP_032410816.1|	36.7	229	229	646	2.33e-41	147
ShaoY_2019_ERR3404634_bin.2_k119_4238_95	SARG|gb|ADZ12699.1|ARO:3005091|RanA	35.8	215	229	258	9.67e-38	131
ShaoY_2019_ERR3404634_bin.2_k119_4238_95	SARG|gb|CDO61516.1|ARO:3003949|efrB	30.0	203	229	362	2.01e-22	92.8
ShaoY_2019_ERR3404634_bin.2_k119_4238_95	SARG|gi|516574297|ref|WP_017949361.1|	30.6	209	229	620	6.44e-21	89.7
ShaoY_2019_ERR3404634_bin.2_k119_4238_95	SARG|gi|928900436|ref|WP_053931243.1|	31.4	220	229	600	8.62e-21	89.4
ShaoY_2019_ERR3404634_bin.2_k119_4238_95	SARG|gi|664579989|ref|WP_031094015.1|	31.4	220	229	601	8.63e-21	89.4
ShaoY_2019_ERR3404634_bin.2_k119_4238_95	SARG|gi|739906046|ref|WP_037756452.1|	30.6	209	229	620	8.74e-21	89.4
ShaoY_2019_ERR3404634_bin.2_k119_4238_95	SARG|gi|930482089|ref|WP_054228897.1|	29.9	221	229	599	2.15e-20	88.2
ShaoY_2019_ERR3404634_bin.2_k119_4238_95	SARG|gi|985844137|ref|WP_060895163.1|	29.9	221	229	599	2.15e-20	88.2
ShaoY_2019_ERR3404634_bin.2_k119_4238_95	SARG|gi|943909899|ref|WP_055545300.1|	31.4	204	229	601	2.16e-20	88.2
ShaoY_2019_ERR3404634_bin.2_k119_4261_4	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	50.8	250	250	255	3.40e-85	253
ShaoY_2019_ERR3404634_bin.2_k119_4261_4	SARG|gi|754964360|ref|WP_042320280.1|	40.5	220	250	648	1.76e-52	179
ShaoY_2019_ERR3404634_bin.2_k119_4261_4	SARG|gi|817104523|ref|WP_046477871.1|	40.0	220	250	648	2.45e-52	178
ShaoY_2019_ERR3404634_bin.2_k119_4261_4	SARG|gi|764278838|ref|WP_044327089.1|	40.0	220	250	648	2.45e-52	178
ShaoY_2019_ERR3404634_bin.2_k119_4261_4	SARG|gi|803568669|ref|WP_046077412.1|	40.9	220	250	648	3.40e-52	178
ShaoY_2019_ERR3404634_bin.2_k119_4261_4	SARG|gi|446110352|ref|WP_000188207.1|	40.9	220	250	648	3.40e-52	178
ShaoY_2019_ERR3404634_bin.2_k119_4261_4	SARG|YP_002382193	40.9	220	250	648	3.40e-52	178
ShaoY_2019_ERR3404634_bin.2_k119_4261_4	SARG|gi|803575554|ref|WP_046081557.1|	40.9	220	250	648	3.40e-52	178
ShaoY_2019_ERR3404634_bin.2_k119_4261_4	SARG|gi|446110351|ref|WP_000188206.1|	40.9	220	250	648	3.40e-52	178
ShaoY_2019_ERR3404634_bin.2_k119_4261_4	SARG|gi|754927849|ref|WP_042284850.1|	40.0	220	250	648	9.10e-52	177
ShaoY_2019_ERR3404634_bin.2_k119_4261_5	NCBI|XSG12257.1|1|1|drcB|drcB||1|||daptomycin_efflux_ABC_transporter_permease_DrcB|AMR|peptide	24.8	602	610	641	1.08e-30	126
ShaoY_2019_ERR3404634_bin.2_k119_4261_6	SARG|VXQ21601.1	37.2	325	358	344	1.37e-62	202
ShaoY_2019_ERR3404634_bin.2_k119_4261_6	SARG|AXY65402.1	38.1	344	358	357	1.53e-61	200
ShaoY_2019_ERR3404634_bin.2_k119_4261_12	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	27.1	225	383	346	2.14e-07	51.2
ShaoY_2019_ERR3404634_bin.2_k119_4261_97	CARD|gb|AAK37618.1|ARO:3005008|TxR	35.7	210	924	318	1.39e-23	101
ShaoY_2019_ERR3404634_bin.2_k119_4261_108	NCBI|ABQ18953.1|1|1|emrD3|emrD3||1|EFFLUX|EFFLUX|multidrug_efflux_MFS_transporter_EmrD-3|AMR|efflux	35.1	348	394	379	1.79e-53	181
ShaoY_2019_ERR3404634_bin.2_k119_4261_108	SARG|gi|1028086745|ref|WP_063845118.1|	28.5	333	394	404	1.98e-31	122
ShaoY_2019_ERR3404634_bin.2_k119_4261_108	SARG|AF252855.1.gene1.p01	28.5	333	394	404	1.98e-31	122
ShaoY_2019_ERR3404634_bin.2_k119_4261_108	SARG|gi|504199699|ref|WP_014386801.1|	28.5	333	394	404	1.98e-31	122
ShaoY_2019_ERR3404634_bin.2_k119_4261_108	SARG|AY034138.1.gene10.p01	28.5	333	394	404	7.13e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4261_108	SARG|gi|504091830|ref|WP_014325824.1|	28.5	333	394	404	1.35e-30	120
ShaoY_2019_ERR3404634_bin.2_k119_4261_108	SARG|gi|1028086691|ref|WP_063845065.1|	28.5	333	394	404	1.35e-30	120
ShaoY_2019_ERR3404634_bin.2_k119_4261_108	SARG|AF231986.2.gene2.p01	28.5	333	394	404	1.35e-30	120
ShaoY_2019_ERR3404634_bin.2_k119_4261_108	SARG|gi|505244440|ref|WP_015431542.1|	28.5	333	394	404	1.86e-30	119
ShaoY_2019_ERR3404634_bin.2_k119_4261_108	SARG|AJ518835.1.gene6.p01	28.5	333	394	404	1.86e-30	119
ShaoY_2019_ERR3404634_bin.2_k119_4387_2	CARD|gb|AAK37618.1|ARO:3005008|TxR	31.0	216	840	318	1.12e-17	84.0
ShaoY_2019_ERR3404634_bin.2_k119_4387_7	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	32.5	292	312	343	9.71e-42	146
ShaoY_2019_ERR3404634_bin.2_k119_4387_7	SARG|gi|447057509|ref|WP_001134765.1|	33.0	306	312	309	1.70e-35	129
ShaoY_2019_ERR3404634_bin.2_k119_4387_7	SARG|gi|500194536|ref|WP_011867743.1|	30.9	311	312	306	8.48e-35	127
ShaoY_2019_ERR3404634_bin.2_k119_4387_7	SARG|gi|447195835|ref|WP_001273091.1|	30.9	311	312	306	8.48e-35	127
ShaoY_2019_ERR3404634_bin.2_k119_4387_7	SARG|gi|445996708|ref|WP_000074563.1|	32.0	306	312	309	9.05e-35	127
ShaoY_2019_ERR3404634_bin.2_k119_4387_7	SARG|P42332	31.5	314	312	306	1.66e-34	126
ShaoY_2019_ERR3404634_bin.2_k119_4387_7	SARG|gi|445996719|ref|WP_000074574.1|	32.7	306	312	309	1.77e-34	126
ShaoY_2019_ERR3404634_bin.2_k119_4387_7	SARG|gi|895736250|emb|COF64653.1|	33.0	306	312	309	1.77e-34	126
ShaoY_2019_ERR3404634_bin.2_k119_4387_7	SARG|gi|445996698|ref|WP_000074553.1|	31.7	306	312	309	1.77e-34	126
ShaoY_2019_ERR3404634_bin.2_k119_4387_7	SARG|gi|447195836|ref|WP_001273092.1|	30.5	311	312	306	2.31e-34	126
ShaoY_2019_ERR3404634_bin.2_k119_4387_16	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	32.2	236	241	255	1.82e-37	130
ShaoY_2019_ERR3404634_bin.2_k119_4387_16	SARG|gb|AAK76137.1|ARO:3000024|patA	30.9	207	241	564	1.14e-22	95.1
ShaoY_2019_ERR3404634_bin.2_k119_4387_16	SARG|gb|WP_104671188.1|ARO:3003948|efrA	31.7	230	241	575	3.94e-22	93.6
ShaoY_2019_ERR3404634_bin.2_k119_4387_16	SARG|gb|CDO61516.1|ARO:3003949|efrB	31.5	200	241	362	8.47e-17	77.4
ShaoY_2019_ERR3404634_bin.2_k119_4387_16	SARG|gi|860594225|ref|WP_048475168.1|	30.6	222	241	620	1.05e-16	77.8
ShaoY_2019_ERR3404634_bin.2_k119_4387_16	SARG|gi|817122037|ref|WP_046494699.1|	32.0	206	241	613	8.69e-16	75.1
ShaoY_2019_ERR3404634_bin.2_k119_4387_16	SARG|gi|496018010|ref|WP_008742581.1|	29.8	205	241	623	1.18e-15	74.7
ShaoY_2019_ERR3404634_bin.2_k119_4387_16	SARG|gi|505420018|ref|WP_015607120.1|	30.3	221	241	603	1.58e-15	74.3
ShaoY_2019_ERR3404634_bin.2_k119_4387_16	SARG|gi|926400371|ref|WP_053728483.1|	33.2	217	241	603	1.58e-15	74.3
ShaoY_2019_ERR3404634_bin.2_k119_4387_16	SARG|gi|695865802|ref|WP_032778631.1|	30.8	221	241	605	3.91e-15	73.2
ShaoY_2019_ERR3404634_bin.2_k119_4387_71	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	36.5	252	334	314	8.41e-36	130
ShaoY_2019_ERR3404634_bin.2_k119_4387_71	SARG|gi|740152780|ref|WP_037997109.1|	35.8	246	334	322	2.78e-34	127
ShaoY_2019_ERR3404634_bin.2_k119_4387_71	SARG|gi|749574782|ref|WP_040203616.1|	35.6	247	334	323	5.50e-34	126
ShaoY_2019_ERR3404634_bin.2_k119_4387_71	SARG|YP_002333394	36.8	247	334	323	5.50e-34	126
ShaoY_2019_ERR3404634_bin.2_k119_4387_71	SARG|AF310956.2.gene5.p01	36.4	247	334	323	2.07e-33	124
ShaoY_2019_ERR3404634_bin.2_k119_4387_71	NCBI|WP_063856701.1|1|1|vanH-B|vanH-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-B|AMR|glycopeptide	36.4	247	334	323	2.07e-33	124
ShaoY_2019_ERR3404634_bin.2_k119_4387_71	SARG|gb|AAB05626.1|ARO:3002943|vanHB	36.3	248	334	323	1.08e-32	122
ShaoY_2019_ERR3404634_bin.2_k119_4387_71	SARG|gi|985522333|ref|WP_060811962.1|	35.9	248	334	323	1.51e-32	122
ShaoY_2019_ERR3404634_bin.2_k119_4387_71	SARG|gi|498515089|ref|WP_010815296.1|	35.5	248	334	323	5.65e-32	120
ShaoY_2019_ERR3404634_bin.2_k119_4387_71	SARG|Q47748	35.9	248	334	323	5.65e-32	120
ShaoY_2019_ERR3404634_bin.2_k119_4387_88	SARG|gi|851899656|ref|WP_048211088.1|	38.9	265	314	660	7.25e-48	169
ShaoY_2019_ERR3404634_bin.2_k119_4387_88	SARG|gi|1002399350|ref|WP_061382108.1|	38.9	265	314	660	1.38e-47	168
ShaoY_2019_ERR3404634_bin.2_k119_4387_88	SARG|gi|757799830|ref|WP_043017032.1|	38.5	265	314	660	3.65e-47	167
ShaoY_2019_ERR3404634_bin.2_k119_4387_88	SARG|gi|489117806|ref|WP_003027650.1|	38.5	265	314	660	1.33e-46	165
ShaoY_2019_ERR3404634_bin.2_k119_4387_88	SARG|YP_002850217	38.1	265	314	660	1.83e-46	165
ShaoY_2019_ERR3404634_bin.2_k119_4387_88	SARG|gi|550713000|ref|WP_022645909.1|	37.5	264	314	660	1.83e-46	165
ShaoY_2019_ERR3404634_bin.2_k119_4387_88	SARG|gi|851965596|ref|WP_048234849.1|	38.1	265	314	660	2.53e-46	164
ShaoY_2019_ERR3404634_bin.2_k119_4387_88	SARG|gi|489931383|ref|WP_003834702.1|	38.1	265	314	660	2.53e-46	164
ShaoY_2019_ERR3404634_bin.2_k119_4387_88	SARG|gi|696369048|ref|WP_032944060.1|	38.1	265	314	660	4.81e-46	164
ShaoY_2019_ERR3404634_bin.2_k119_4387_88	SARG|gi|765458296|ref|WP_044714032.1|	38.1	265	314	660	6.64e-46	163
ShaoY_2019_ERR3404634_bin.2_k119_4387_91	CARD|gb|WKR28567.1|ARO:3007678|IreK	98.9	718	719	718	0.0	1328
ShaoY_2019_ERR3404634_bin.2_k119_4387_105	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	31.8	211	336	255	1.49e-29	112
ShaoY_2019_ERR3404634_bin.2_k119_4387_105	SARG|gi|924503108|ref|WP_053510027.1|	31.5	238	336	648	7.44e-21	92.4
ShaoY_2019_ERR3404634_bin.2_k119_4387_105	SARG|gi|896325272|ref|WP_049294291.1|	32.2	233	336	648	1.00e-20	92.0
ShaoY_2019_ERR3404634_bin.2_k119_4387_105	SARG|gi|555268037|ref|WP_023249477.1|	31.3	240	336	648	1.35e-20	91.7
ShaoY_2019_ERR3404634_bin.2_k119_4387_105	SARG|gi|924626178|ref|WP_053530123.1|	31.3	240	336	648	1.35e-20	91.7
ShaoY_2019_ERR3404634_bin.2_k119_4387_105	SARG|gi|639216333|ref|WP_024554080.1|	31.8	233	336	648	2.44e-20	90.9
ShaoY_2019_ERR3404634_bin.2_k119_4387_105	SARG|gi|922019548|ref|WP_053299973.1|	30.8	240	336	648	4.42e-20	90.1
ShaoY_2019_ERR3404634_bin.2_k119_4387_105	SARG|YP_001571041	30.8	240	336	648	4.42e-20	90.1
ShaoY_2019_ERR3404634_bin.2_k119_4387_105	SARG|gi|960873409|ref|WP_058345546.1|	30.8	240	336	648	4.42e-20	90.1
ShaoY_2019_ERR3404634_bin.2_k119_4387_105	SARG|gi|923061916|ref|WP_053445667.1|	30.8	240	336	648	4.42e-20	90.1
ShaoY_2019_ERR3404634_bin.2_k119_4596_31	SARG|gb|AAC74000.1|ARO:3003950|msbA	32.8	539	572	582	2.84e-92	293
ShaoY_2019_ERR3404634_bin.2_k119_4596_31	SARG|gb|WP_104671188.1|ARO:3003948|efrA	31.5	556	572	575	5.03e-91	290
ShaoY_2019_ERR3404634_bin.2_k119_4596_31	SARG|gi|1045390184|ref|WP_065479071.1|	30.6	578	572	605	9.92e-87	280
ShaoY_2019_ERR3404634_bin.2_k119_4596_31	SARG|gi|948137056|ref|WP_056795395.1|	30.4	578	572	602	1.37e-85	276
ShaoY_2019_ERR3404634_bin.2_k119_4596_31	SARG|gi|664180077|ref|WP_030714054.1|	30.7	579	572	605	1.48e-85	276
ShaoY_2019_ERR3404634_bin.2_k119_4596_31	SARG|gi|748767925|ref|WP_040019608.1|	31.8	581	572	623	1.62e-85	277
ShaoY_2019_ERR3404634_bin.2_k119_4596_31	SARG|gi|695887424|ref|WP_032788534.1|	31.4	582	572	605	2.90e-85	276
ShaoY_2019_ERR3404634_bin.2_k119_4596_31	SARG|gi|764446018|ref|WP_044369325.1|	30.3	578	572	605	2.90e-85	276
ShaoY_2019_ERR3404634_bin.2_k119_4596_31	SARG|gi|663350985|ref|WP_030349761.1|	31.1	578	572	613	3.51e-85	276
ShaoY_2019_ERR3404634_bin.2_k119_4596_31	SARG|gi|928900436|ref|WP_053931243.1|	30.8	572	572	600	3.60e-85	275
ShaoY_2019_ERR3404634_bin.2_k119_4596_46	SARG|gb|AJD73064.1|ARO:3001301|RlmA(II)	34.8	270	282	282	2.98e-45	153
ShaoY_2019_ERR3404634_bin.2_k119_4596_52	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_3	23.9	427	402	409	1.10e-17	83.2
ShaoY_2019_ERR3404634_bin.2_k119_4596_52	SARG|gb|BAE85481.1|ARO:3003727|vanKI	23.1	424	402	375	5.21e-17	80.9
ShaoY_2019_ERR3404634_bin.2_k119_4596_58	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	33.3	219	362	579	5.26e-22	96.3
ShaoY_2019_ERR3404634_bin.2_k119_4596_58	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	34.4	218	362	579	1.28e-21	95.1
ShaoY_2019_ERR3404634_bin.2_k119_4596_58	SARG|gi|951389844|ref|WP_057765492.1|	29.2	195	362	492	6.35e-15	74.7
ShaoY_2019_ERR3404634_bin.2_k119_4596_92	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	35.9	198	397	255	5.82e-36	131
ShaoY_2019_ERR3404634_bin.2_k119_4596_92	SARG|gb|ADZ12699.1|ARO:3005091|RanA	31.2	215	397	258	1.77e-32	122
ShaoY_2019_ERR3404634_bin.2_k119_4596_92	SARG|gb|AAC75271.1|ARO:3003952|yojI	35.7	207	397	547	7.42e-23	99.4
ShaoY_2019_ERR3404634_bin.2_k119_4596_94	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	39.8	532	649	655	8.35e-121	372
ShaoY_2019_ERR3404634_bin.2_k119_4596_94	megares|MEG_4323|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	39.8	532	649	655	6.49e-120	370
ShaoY_2019_ERR3404634_bin.2_k119_4596_94	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	39.7	532	649	655	1.29e-119	369
ShaoY_2019_ERR3404634_bin.2_k119_4596_94	SARG|gb|AKA86814|ARO:3003746|optrA	39.7	532	649	655	1.29e-119	369
ShaoY_2019_ERR3404634_bin.2_k119_4596_94	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	39.7	532	649	655	1.81e-119	369
ShaoY_2019_ERR3404634_bin.2_k119_4596_94	megares|MEG_4311|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	39.7	532	649	655	2.55e-119	369
ShaoY_2019_ERR3404634_bin.2_k119_4596_94	megares|MEG_4305|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	39.7	532	649	655	2.55e-119	369
ShaoY_2019_ERR3404634_bin.2_k119_4596_94	megares|MEG_4321|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	39.7	532	649	655	3.58e-119	368
ShaoY_2019_ERR3404634_bin.2_k119_4596_94	megares|MEG_4317|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	39.7	532	649	655	3.58e-119	368
ShaoY_2019_ERR3404634_bin.2_k119_4596_94	megares|MEG_4314|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	39.7	532	649	655	3.58e-119	368
ShaoY_2019_ERR3404634_bin.2_k119_4596_122	CARD|gb|AAN28945.1|ARO:3003785|Ctra_murA_FOF	36.3	432	434	444	1.14e-69	226
ShaoY_2019_ERR3404634_bin.2_k119_4596_132	SARG|gb|WP_104671188.1|ARO:3003948|efrA	43.2	553	576	575	1.46e-148	439
ShaoY_2019_ERR3404634_bin.2_k119_4596_132	SARG|gb|AAK76137.1|ARO:3000024|patA	32.8	564	576	564	2.20e-103	322
ShaoY_2019_ERR3404634_bin.2_k119_4596_132	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	30.5	560	576	579	1.28e-69	234
ShaoY_2019_ERR3404634_bin.2_k119_4596_132	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	30.0	560	576	579	1.28e-69	234
ShaoY_2019_ERR3404634_bin.2_k119_4596_132	SARG|gi|1045390184|ref|WP_065479071.1|	27.1	539	576	605	1.67e-63	218
ShaoY_2019_ERR3404634_bin.2_k119_4596_132	SARG|gi|944470764|ref|WP_055701183.1|	27.8	540	576	601	7.96e-62	213
ShaoY_2019_ERR3404634_bin.2_k119_4596_132	SARG|gi|497748188|ref|WP_010062372.1|	26.9	539	576	605	8.58e-62	213
ShaoY_2019_ERR3404634_bin.2_k119_4596_132	SARG|gi|695865802|ref|WP_032778631.1|	26.7	539	576	605	8.58e-62	213
ShaoY_2019_ERR3404634_bin.2_k119_4596_132	SARG|gi|764446018|ref|WP_044369325.1|	26.7	539	576	605	1.19e-61	213
ShaoY_2019_ERR3404634_bin.2_k119_4596_132	SARG|gi|926351744|ref|WP_053683383.1|	27.5	539	576	648	1.33e-61	214
ShaoY_2019_ERR3404634_bin.2_k119_4596_133	SARG|gb|AAK76136.1|ARO:3000025|patB	35.4	593	623	588	1.19e-117	361
ShaoY_2019_ERR3404634_bin.2_k119_4596_133	SARG|gb|AYV52072.1|ARO:3002882|lmrD	37.5	514	623	664	2.97e-107	337
ShaoY_2019_ERR3404634_bin.2_k119_4596_133	SARG|gb|CDO61516.1|ARO:3003949|efrB	47.3	351	623	362	2.24e-100	309
ShaoY_2019_ERR3404634_bin.2_k119_4596_133	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	33.6	518	623	579	7.63e-86	278
ShaoY_2019_ERR3404634_bin.2_k119_4596_133	SARG|gi|944009777|ref|WP_055601444.1|	33.1	511	623	628	2.50e-85	278
ShaoY_2019_ERR3404634_bin.2_k119_4596_133	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	33.7	523	623	579	6.38e-83	270
ShaoY_2019_ERR3404634_bin.2_k119_4596_133	SARG|gi|947982677|ref|WP_056642336.1|	32.3	511	623	626	7.12e-83	271
ShaoY_2019_ERR3404634_bin.2_k119_4596_133	SARG|gi|639892676|ref|WP_024755698.1|	32.3	511	623	631	7.98e-83	271
ShaoY_2019_ERR3404634_bin.2_k119_4596_133	SARG|gi|516574297|ref|WP_017949361.1|	33.1	510	623	620	1.69e-82	270
ShaoY_2019_ERR3404634_bin.2_k119_4596_133	SARG|gi|926376632|ref|WP_053705806.1|	32.5	532	623	620	1.69e-82	270
ShaoY_2019_ERR3404634_bin.2_k119_4596_185	SARG|gi|542061059|gb|ERI11611.1|	32.4	207	346	316	2.19e-36	132
ShaoY_2019_ERR3404634_bin.2_k119_4596_185	SARG|YP_001373621	29.7	290	346	318	1.21e-35	130
ShaoY_2019_ERR3404634_bin.2_k119_4596_197	NCBI|WP_063852700.1|1|1|mecA2|mecA2|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecA2|AMR|beta-lactam	33.9	664	681	668	2.26e-111	349
ShaoY_2019_ERR3404634_bin.2_k119_4596_197	NCBI|WP_063852694.1|1|1|mecA2|mecA2|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecA2|AMR|beta-lactam	33.6	658	681	668	3.43e-110	346
ShaoY_2019_ERR3404634_bin.2_k119_4596_197	SARG|gi|686392252|ref|WP_031906577.1|	35.3	584	681	668	1.10e-107	340
ShaoY_2019_ERR3404634_bin.2_k119_4596_197	SARG|gi|446643961|ref|WP_000721307.1|	35.6	584	681	668	1.54e-107	339
ShaoY_2019_ERR3404634_bin.2_k119_4596_197	SARG|gi|686316946|ref|WP_031873770.1|	35.6	584	681	668	1.54e-107	339
ShaoY_2019_ERR3404634_bin.2_k119_4596_197	SARG|gi|446643957|ref|WP_000721303.1|	35.6	584	681	668	2.16e-107	339
ShaoY_2019_ERR3404634_bin.2_k119_4596_197	SARG|gi|686330880|ref|WP_031879536.1|	35.6	584	681	668	2.16e-107	339
ShaoY_2019_ERR3404634_bin.2_k119_4596_197	SARG|gi|686132960|ref|WP_031774065.1|	35.6	584	681	668	2.16e-107	339
ShaoY_2019_ERR3404634_bin.2_k119_4596_197	SARG|gi|1028095795|ref|WP_063852683.1|	35.6	584	681	668	4.26e-107	338
ShaoY_2019_ERR3404634_bin.2_k119_4596_197	SARG|gi|686404991|ref|WP_031911502.1|	35.4	584	681	668	4.26e-107	338
ShaoY_2019_ERR3404634_bin.2_k119_4596_212	SARG|AAV80410	24.6	349	612	651	2.03e-26	113
ShaoY_2019_ERR3404634_bin.2_k119_4596_212	SARG|L42544.gene.p01	24.4	349	612	651	1.13e-25	110
ShaoY_2019_ERR3404634_bin.2_k119_4596_212	SARG|AJ514254.gene.p01	24.0	525	612	640	1.06e-24	107
ShaoY_2019_ERR3404634_bin.2_k119_4596_212	SARG|AAK17952	39.2	130	612	639	2.10e-20	94.4
ShaoY_2019_ERR3404634_bin.2_k119_4596_212	SARG|ABN11268	39.2	130	612	639	2.10e-20	94.4
ShaoY_2019_ERR3404634_bin.2_k119_4596_212	SARG|ABG21123	38.5	130	612	639	2.78e-20	94.0
ShaoY_2019_ERR3404634_bin.2_k119_4596_212	SARG|AAY63943	38.5	130	612	639	2.78e-20	94.0
ShaoY_2019_ERR3404634_bin.2_k119_4596_212	SARG|gi|446614384|ref|WP_000691730.1|	38.5	130	612	639	2.78e-20	94.0
ShaoY_2019_ERR3404634_bin.2_k119_4596_212	SARG|AAB05246	38.5	130	612	639	2.78e-20	94.0
ShaoY_2019_ERR3404634_bin.2_k119_4596_212	SARG|ABW24731	38.5	130	612	639	2.78e-20	94.0
ShaoY_2019_ERR3404634_bin.2_k119_4596_233	SARG|ZP_04433866	100	276	277	288	1.32e-195	535
ShaoY_2019_ERR3404634_bin.2_k119_4596_233	SARG|ZP_03984017	99.6	276	277	288	2.65e-195	534
ShaoY_2019_ERR3404634_bin.2_k119_4596_233	SARG|ZP_03949893	99.6	276	277	288	5.36e-195	533
ShaoY_2019_ERR3404634_bin.2_k119_4596_233	SARG|ZP_03938934	64.9	265	277	288	4.52e-122	349
ShaoY_2019_ERR3404634_bin.2_k119_4596_233	SARG|ZP_03941859	64.9	265	277	288	1.29e-121	348
ShaoY_2019_ERR3404634_bin.2_k119_4596_233	SARG|ZP_03945515	63.8	265	277	291	2.88e-121	347
ShaoY_2019_ERR3404634_bin.2_k119_4596_233	SARG|ZP_04528247	61.7	274	277	279	1.07e-113	327
ShaoY_2019_ERR3404634_bin.2_k119_4596_233	SARG|YP_002929946	56.9	269	277	282	5.01e-103	300
ShaoY_2019_ERR3404634_bin.2_k119_4596_233	SARG|ZP_03958019	53.0	285	277	317	3.95e-98	289
ShaoY_2019_ERR3404634_bin.2_k119_4596_233	SARG|YP_002937728	55.2	277	277	289	1.82e-97	286
ShaoY_2019_ERR3404634_bin.2_k119_4596_240	SARG|gb|AJP77071|ARO:3003714|PEDO-2	29.6	135	209	285	3.93e-08	51.2
ShaoY_2019_ERR3404634_bin.2_k119_4596_240	SARG|gb|AJP77085|ARO:3003717|ESP-1	25.2	135	209	290	6.02e-07	47.8
ShaoY_2019_ERR3404634_bin.2_k119_4596_240	SARG|gb|AAF89148.1|ARO:3004813|GOB-6	26.7	135	209	252	9.60e-07	47.0
ShaoY_2019_ERR3404634_bin.2_k119_4596_240	ResF|blaGOB-6_1_AF189292_1	26.7	135	209	290	1.10e-06	47.0
ShaoY_2019_ERR3404634_bin.2_k119_4596_240	NCBI|WP_069147617.1|1|1|blaGOB-6|blaGOB|hydrolase|2|||subclass_B3_metallo-beta-lactamase_GOB-6|AMR|beta-lactam	26.7	135	209	290	1.10e-06	47.0
ShaoY_2019_ERR3404634_bin.2_k119_4596_240	SARG|gb|AAT68579.1|ARO:3004804|GOB-12	26.7	135	209	290	2.00e-06	46.2
ShaoY_2019_ERR3404634_bin.2_k119_4596_240	SARG|gb|AAT68576.1|ARO:3004816|GOB-9	27.4	135	209	290	2.69e-06	45.8
ShaoY_2019_ERR3404634_bin.2_k119_4596_240	SARG|gb|AAF89149.1|ARO:3004811|GOB-4	26.7	135	209	252	3.21e-06	45.4
ShaoY_2019_ERR3404634_bin.2_k119_4596_240	NCBI|WP_159108984.1|1|1|blaGOB-52|blaGOB|hydrolase|2|CARBAPENEM|beta-lactam|subclass_B3_metallo-beta-lactamase_GOB-52|AMR|beta-lactam	26.7	135	209	290	3.63e-06	45.4
ShaoY_2019_ERR3404634_bin.2_k119_4596_240	SARG|gb|WP_024566153.1|ARO:3005670|GOB-21	26.7	135	209	290	3.63e-06	45.4
ShaoY_2019_ERR3404634_bin.2_k119_4596_274	SARG|gi|664556405|ref|WP_031071225.1|	30.8	237	257	602	3.23e-17	79.7
ShaoY_2019_ERR3404634_bin.2_k119_4596_274	SARG|gi|748767925|ref|WP_040019608.1|	30.6	222	257	623	4.42e-17	79.3
ShaoY_2019_ERR3404634_bin.2_k119_4596_274	SARG|gi|817122037|ref|WP_046494699.1|	31.2	231	257	613	8.03e-17	78.6
ShaoY_2019_ERR3404634_bin.2_k119_4596_274	SARG|gi|930482089|ref|WP_054228897.1|	29.7	246	257	599	1.45e-16	77.8
ShaoY_2019_ERR3404634_bin.2_k119_4596_274	SARG|gi|985844137|ref|WP_060895163.1|	29.7	246	257	599	1.45e-16	77.8
ShaoY_2019_ERR3404634_bin.2_k119_4596_274	SARG|gi|860594225|ref|WP_048475168.1|	29.1	247	257	620	1.47e-16	77.8
ShaoY_2019_ERR3404634_bin.2_k119_4596_274	SARG|gi|917166849|ref|WP_051773561.1|	29.3	229	257	620	1.99e-16	77.4
ShaoY_2019_ERR3404634_bin.2_k119_4596_274	SARG|gi|496018010|ref|WP_008742581.1|	28.6	248	257	623	1.99e-16	77.4
ShaoY_2019_ERR3404634_bin.2_k119_4596_274	SARG|gi|917155568|ref|WP_051762280.1|	29.3	229	257	620	2.69e-16	77.0
ShaoY_2019_ERR3404634_bin.2_k119_4596_274	SARG|gi|953808775|ref|WP_058042812.1|	30.8	237	257	608	3.60e-16	76.6
ShaoY_2019_ERR3404634_bin.2_k119_4596_318	SARG|gi|1004359922|gb|AMP42228.1|	25.2	432	612	639	3.39e-25	109
ShaoY_2019_ERR3404634_bin.2_k119_4596_318	SARG|ABN79417	25.1	435	612	639	7.97e-25	108
ShaoY_2019_ERR3404634_bin.2_k119_4596_318	SARG|AAO42740	25.1	435	612	639	7.97e-25	108
ShaoY_2019_ERR3404634_bin.2_k119_4596_318	SARG|AY485126.gene.p01	25.1	435	612	639	7.97e-25	108
ShaoY_2019_ERR3404634_bin.2_k119_4596_318	megares|MEG_7175|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	25.1	435	612	639	7.97e-25	108
ShaoY_2019_ERR3404634_bin.2_k119_4596_318	SARG|AAV80410	23.5	434	612	651	8.24e-25	108
ShaoY_2019_ERR3404634_bin.2_k119_4596_318	megares|MEG_7170|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	25.1	435	612	629	1.03e-24	107
ShaoY_2019_ERR3404634_bin.2_k119_4596_318	ResF|tet(O/W)_4_AM889121_1	25.1	435	612	639	1.06e-24	107
ShaoY_2019_ERR3404634_bin.2_k119_4596_318	megares|MEG_7169|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	25.1	435	612	629	1.81e-24	107
ShaoY_2019_ERR3404634_bin.2_k119_4596_318	megares|MEG_7173|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	25.1	435	612	629	1.81e-24	107
ShaoY_2019_ERR3404634_bin.2_k119_4596_343	SARG|gb|CDO61516.1|ARO:3003949|efrB	52.4	296	578	362	1.94e-96	297
ShaoY_2019_ERR3404634_bin.2_k119_4596_343	SARG|gb|AYV52072.1|ARO:3002882|lmrD	38.3	501	578	664	7.76e-89	287
ShaoY_2019_ERR3404634_bin.2_k119_4596_343	SARG|gb|AAK76136.1|ARO:3000025|patB	34.7	530	578	588	1.51e-86	279
ShaoY_2019_ERR3404634_bin.2_k119_4596_343	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	34.5	495	578	579	1.29e-85	276
ShaoY_2019_ERR3404634_bin.2_k119_4596_343	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	33.2	515	578	579	1.45e-83	271
ShaoY_2019_ERR3404634_bin.2_k119_4596_343	SARG|gb|AAC74000.1|ARO:3003950|msbA	32.7	507	578	582	5.55e-78	256
ShaoY_2019_ERR3404634_bin.2_k119_4596_343	SARG|gi|926376632|ref|WP_053705806.1|	30.8	517	578	620	3.05e-71	239
ShaoY_2019_ERR3404634_bin.2_k119_4596_343	SARG|gi|517347347|ref|WP_018522839.1|	31.1	528	578	601	5.55e-71	238
ShaoY_2019_ERR3404634_bin.2_k119_4596_343	SARG|gi|799286378|ref|WP_045936958.1|	30.8	517	578	620	5.92e-71	238
ShaoY_2019_ERR3404634_bin.2_k119_4596_343	SARG|gi|917127754|ref|WP_051734466.1|	30.8	517	578	620	5.92e-71	238
ShaoY_2019_ERR3404634_bin.2_k119_4596_344	SARG|gb|WP_104671188.1|ARO:3003948|efrA	38.9	571	576	575	4.97e-119	363
ShaoY_2019_ERR3404634_bin.2_k119_4596_344	SARG|gb|AAK76137.1|ARO:3000024|patA	32.1	567	576	564	3.92e-92	293
ShaoY_2019_ERR3404634_bin.2_k119_4596_344	SARG|gi|1045390184|ref|WP_065479071.1|	28.6	545	576	605	1.18e-60	210
ShaoY_2019_ERR3404634_bin.2_k119_4596_344	SARG|gi|664194237|ref|WP_030727956.1|	29.0	545	576	605	4.34e-60	209
ShaoY_2019_ERR3404634_bin.2_k119_4596_344	SARG|gi|928900436|ref|WP_053931243.1|	27.9	541	576	600	1.46e-59	207
ShaoY_2019_ERR3404634_bin.2_k119_4596_344	SARG|gi|664579989|ref|WP_031094015.1|	27.9	541	576	601	1.49e-59	207
ShaoY_2019_ERR3404634_bin.2_k119_4596_344	SARG|gi|664317010|ref|WP_030845774.1|	28.8	545	576	605	1.60e-59	207
ShaoY_2019_ERR3404634_bin.2_k119_4596_344	SARG|gi|663286402|ref|WP_030292859.1|	28.8	545	576	605	1.60e-59	207
ShaoY_2019_ERR3404634_bin.2_k119_4596_344	SARG|gi|663342223|ref|WP_030341347.1|	28.8	545	576	605	1.60e-59	207
ShaoY_2019_ERR3404634_bin.2_k119_4596_344	SARG|gi|759527374|ref|WP_043247487.1|	28.8	545	576	605	1.60e-59	207
ShaoY_2019_ERR3404634_bin.2_k119_4596_366	megares|MEG_727|Drugs|beta-lactam|Class_C_betalactamases|AMPC_1	38.0	405	413	415	2.65e-100	303
ShaoY_2019_ERR3404634_bin.2_k119_4619_8	SARG|AF170880.4.gene1.p01	30.2	301	709	615	3.95e-30	125
ShaoY_2019_ERR3404634_bin.2_k119_4619_8	SARG|gi|748767925|ref|WP_040019608.1|	28.8	326	709	623	4.14e-30	125
ShaoY_2019_ERR3404634_bin.2_k119_4619_8	SARG|gi|930482089|ref|WP_054228897.1|	28.9	329	709	599	6.38e-30	124
ShaoY_2019_ERR3404634_bin.2_k119_4619_8	SARG|gi|655401130|ref|WP_028800283.1|	30.3	333	709	599	6.38e-30	124
ShaoY_2019_ERR3404634_bin.2_k119_4619_8	SARG|gi|985844137|ref|WP_060895163.1|	28.9	329	709	599	6.38e-30	124
ShaoY_2019_ERR3404634_bin.2_k119_4619_8	SARG|gi|493394434|ref|WP_006350564.1|	30.1	326	709	602	6.50e-30	124
ShaoY_2019_ERR3404634_bin.2_k119_4619_8	SARG|gi|926400371|ref|WP_053728483.1|	30.3	327	709	603	8.72e-30	124
ShaoY_2019_ERR3404634_bin.2_k119_4619_8	SARG|gi|558888514|ref|WP_023543283.1|	29.9	301	709	615	1.25e-29	123
ShaoY_2019_ERR3404634_bin.2_k119_4619_8	SARG|gi|655413091|ref|WP_028811890.1|	30.1	326	709	603	1.55e-29	123
ShaoY_2019_ERR3404634_bin.2_k119_4619_8	SARG|gi|799286378|ref|WP_045936958.1|	26.3	480	709	620	2.28e-29	122
ShaoY_2019_ERR3404634_bin.2_k119_4832_3	SARG|gi|497748188|ref|WP_010062372.1|	27.3	560	560	605	4.36e-62	214
ShaoY_2019_ERR3404634_bin.2_k119_4832_3	SARG|gi|496018010|ref|WP_008742581.1|	28.3	562	560	623	1.62e-61	213
ShaoY_2019_ERR3404634_bin.2_k119_4832_3	SARG|gi|764446018|ref|WP_044369325.1|	27.3	560	560	605	1.62e-61	212
ShaoY_2019_ERR3404634_bin.2_k119_4832_3	SARG|gi|1045390184|ref|WP_065479071.1|	27.3	560	560	605	1.62e-61	212
ShaoY_2019_ERR3404634_bin.2_k119_4832_3	SARG|gi|664180077|ref|WP_030714054.1|	27.1	560	560	605	2.25e-61	212
ShaoY_2019_ERR3404634_bin.2_k119_4832_3	SARG|gi|695865802|ref|WP_032778631.1|	27.1	560	560	605	4.33e-61	211
ShaoY_2019_ERR3404634_bin.2_k119_4832_3	SARG|gi|664170108|ref|WP_030704355.1|	27.7	560	560	603	8.05e-61	210
ShaoY_2019_ERR3404634_bin.2_k119_4832_3	SARG|gi|926351744|ref|WP_053683383.1|	28.5	562	560	648	1.27e-60	211
ShaoY_2019_ERR3404634_bin.2_k119_4832_3	SARG|AF170880.4.gene1.p01	27.6	561	560	615	1.92e-60	209
ShaoY_2019_ERR3404634_bin.2_k119_4832_3	SARG|gi|501350226|ref|WP_012381861.1|	27.5	560	560	603	2.15e-60	209
ShaoY_2019_ERR3404634_bin.2_k119_4832_71	SARG|gi|446048013|ref|WP_000125868.1|	30.1	272	523	648	5.93e-26	110
ShaoY_2019_ERR3404634_bin.2_k119_4832_71	SARG|gi|1028090136|ref|WP_063847814.1|	32.5	200	523	646	7.86e-23	101
ShaoY_2019_ERR3404634_bin.2_k119_4832_71	SARG|gi|736472622|ref|WP_034494292.1|	29.5	275	523	648	1.40e-22	100
ShaoY_2019_ERR3404634_bin.2_k119_4832_71	SARG|gi|1035717981|ref|WP_064557480.1|	28.4	275	523	648	7.60e-21	95.1
ShaoY_2019_ERR3404634_bin.2_k119_4832_71	SARG|gi|1035670474|ref|WP_064517458.1|	28.4	275	523	648	1.01e-20	94.7
ShaoY_2019_ERR3404634_bin.2_k119_4832_71	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	26.8	276	523	293	3.12e-20	90.1
ShaoY_2019_ERR3404634_bin.2_k119_4832_71	SARG|YP_001588793	28.4	208	523	648	1.15e-16	82.0
ShaoY_2019_ERR3404634_bin.2_k119_4832_71	SARG|gi|923061916|ref|WP_053445667.1|	27.8	223	523	648	2.67e-16	80.9
ShaoY_2019_ERR3404634_bin.2_k119_4832_71	SARG|gi|487407385|ref|WP_001675419.1|	27.8	223	523	648	3.54e-16	80.5
ShaoY_2019_ERR3404634_bin.2_k119_4832_71	SARG|gi|487661511|ref|WP_001751648.1|	27.8	223	523	648	3.54e-16	80.5
ShaoY_2019_ERR3404634_bin.2_k119_4832_79	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	26.9	234	267	307	1.73e-21	90.5
ShaoY_2019_ERR3404634_bin.2_k119_4832_79	SARG|gb|APB03219.1|ARO:3003986|TaeA	27.8	248	267	648	1.33e-19	87.0
ShaoY_2019_ERR3404634_bin.2_k119_4832_79	NCBI|AKC61310.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	27.8	216	267	552	8.32e-15	72.8
ShaoY_2019_ERR3404634_bin.2_k119_4832_79	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	27.5	233	267	568	2.06e-14	71.6
ShaoY_2019_ERR3404634_bin.2_k119_4832_79	SARG|FR772051.1.gene9.p01	28.4	194	267	524	3.60e-14	70.9
ShaoY_2019_ERR3404634_bin.2_k119_4832_79	SARG|gb|AHB37625.1|ARO:3004715|vga(E)	26.9	216	267	524	4.86e-14	70.5
ShaoY_2019_ERR3404634_bin.2_k119_4832_79	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	26.7	187	267	461	1.60e-12	65.9
ShaoY_2019_ERR3404634_bin.2_k119_4832_79	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	26.2	187	267	461	2.31e-11	62.4
ShaoY_2019_ERR3404634_bin.2_k119_4832_79	SARG|gb|QQA64075.1|ARO:3007043|msr(I)	25.6	203	267	485	1.88e-10	59.7
ShaoY_2019_ERR3404634_bin.2_k119_4832_79	SARG|gi|686436876|ref|WP_031922735.1|	24.0	204	267	491	1.89e-10	59.7
ShaoY_2019_ERR3404634_bin.2_k119_4832_88	SARG|L42544.gene.p01	27.6	670	694	651	1.37e-78	263
ShaoY_2019_ERR3404634_bin.2_k119_4832_88	SARG|AAV80410	27.6	670	694	651	1.90e-78	262
ShaoY_2019_ERR3404634_bin.2_k119_4832_88	megares|MEG_7174|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	29.2	672	694	629	1.22e-75	254
ShaoY_2019_ERR3404634_bin.2_k119_4832_88	ResF|tet(O/W)_2_AM889119_1	29.2	672	694	639	1.51e-75	254
ShaoY_2019_ERR3404634_bin.2_k119_4832_88	megares|MEG_7173|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	29.2	671	694	629	3.28e-75	253
ShaoY_2019_ERR3404634_bin.2_k119_4832_88	ResF|tet(O/W)_1_AM889118_1	29.2	671	694	639	4.06e-75	253
ShaoY_2019_ERR3404634_bin.2_k119_4832_88	SARG|AY485126.gene.p01	29.1	671	694	639	5.64e-75	253
ShaoY_2019_ERR3404634_bin.2_k119_4832_88	megares|MEG_7163|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	29.2	671	694	629	6.34e-75	252
ShaoY_2019_ERR3404634_bin.2_k119_4832_88	megares|MEG_7170|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	29.2	671	694	629	6.34e-75	252
ShaoY_2019_ERR3404634_bin.2_k119_4832_88	ResF|tet(O/W)_4_AM889121_1	29.2	671	694	639	7.85e-75	252
ShaoY_2019_ERR3404634_bin.2_k119_4832_89	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	35.9	131	396	639	7.96e-14	72.0
ShaoY_2019_ERR3404634_bin.2_k119_4832_123	SARG|gb|AAK76137.1|ARO:3000024|patA	34.4	224	280	564	2.87e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4832_123	SARG|gi|754951242|ref|WP_042307417.1|	35.1	231	280	648	4.01e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4832_123	SARG|gi|740856590|ref|WP_038641842.1|	35.1	231	280	648	4.01e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4832_123	SARG|gi|493734654|ref|WP_006683876.1|	35.1	231	280	648	4.01e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4832_123	SARG|gi|639216333|ref|WP_024554080.1|	33.2	241	280	648	5.46e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4832_123	SARG|gi|491270241|ref|WP_005128370.1|	34.6	231	280	648	7.44e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4832_123	SARG|gi|851913025|ref|WP_048215946.1|	34.6	231	280	648	7.44e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4832_123	SARG|gi|851902043|ref|WP_048212057.1|	34.6	231	280	648	7.44e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4832_123	SARG|gi|489930965|ref|WP_003834285.1|	34.6	231	280	648	7.44e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4832_123	SARG|gi|992380339|ref|WP_061067665.1|	34.6	231	280	648	7.44e-31	120
ShaoY_2019_ERR3404634_bin.2_k119_4832_124	SARG|gi|500448961|gb|EOP61695.1|	31.8	214	290	306	8.24e-29	110
ShaoY_2019_ERR3404634_bin.2_k119_4832_124	SARG|ABB80128	32.5	234	290	306	8.24e-29	110
ShaoY_2019_ERR3404634_bin.2_k119_4832_124	SARG|P42332	32.9	213	290	306	1.15e-28	110
ShaoY_2019_ERR3404634_bin.2_k119_4832_124	SARG|gi|500465078|gb|EOP76697.1|	31.8	214	290	306	1.15e-28	110
ShaoY_2019_ERR3404634_bin.2_k119_4832_124	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	32.9	213	290	306	1.15e-28	110
ShaoY_2019_ERR3404634_bin.2_k119_4832_124	SARG|gi|510143239|gb|AGN36970.1|	32.9	213	290	313	1.30e-28	110
ShaoY_2019_ERR3404634_bin.2_k119_4832_124	SARG|YP_001373621	32.1	212	290	318	1.98e-28	110
ShaoY_2019_ERR3404634_bin.2_k119_4832_124	SARG|gi|447195835|ref|WP_001273091.1|	31.1	212	290	306	1.16e-27	107
ShaoY_2019_ERR3404634_bin.2_k119_4832_124	SARG|gi|500194536|ref|WP_011867743.1|	31.9	213	290	306	2.24e-27	107
ShaoY_2019_ERR3404634_bin.2_k119_4832_124	SARG|gi|447195836|ref|WP_001273092.1|	31.1	212	290	306	2.24e-27	107
ShaoY_2019_ERR3404634_bin.2_k119_4832_131	SARG|gi|803568669|ref|WP_046077412.1|	39.7	232	247	648	1.41e-39	143
ShaoY_2019_ERR3404634_bin.2_k119_4832_131	SARG|gi|446110352|ref|WP_000188207.1|	39.7	232	247	648	1.41e-39	143
ShaoY_2019_ERR3404634_bin.2_k119_4832_131	SARG|YP_002382193	39.7	232	247	648	1.41e-39	143
ShaoY_2019_ERR3404634_bin.2_k119_4832_131	SARG|gi|803575554|ref|WP_046081557.1|	39.7	232	247	648	1.41e-39	143
ShaoY_2019_ERR3404634_bin.2_k119_4832_131	SARG|gi|446110351|ref|WP_000188206.1|	39.7	232	247	648	1.41e-39	143
ShaoY_2019_ERR3404634_bin.2_k119_4832_131	SARG|gi|696368937|ref|WP_032943949.1|	38.1	223	247	648	3.65e-39	142
ShaoY_2019_ERR3404634_bin.2_k119_4832_131	SARG|gi|851913025|ref|WP_048215946.1|	38.1	223	247	648	3.65e-39	142
ShaoY_2019_ERR3404634_bin.2_k119_4832_131	SARG|YP_002850060	38.1	223	247	648	3.65e-39	142
ShaoY_2019_ERR3404634_bin.2_k119_4832_131	SARG|gi|489930965|ref|WP_003834285.1|	38.1	223	247	648	3.65e-39	142
ShaoY_2019_ERR3404634_bin.2_k119_4832_131	SARG|gi|696361545|ref|WP_032936694.1|	38.1	223	247	648	5.02e-39	142
ShaoY_2019_ERR3404634_bin.2_k119_4832_135	SARG|M58472.1.gene1.p01	43.8	64	282	209	6.18e-11	59.7
ShaoY_2019_ERR3404634_bin.2_k119_4832_135	NCBI|WP_031281281.1|1|1|catB|catB|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B_phenicol_O-acetyltransferase|AMR|phenicol	33.7	86	282	210	4.00e-10	57.4
ShaoY_2019_ERR3404634_bin.2_k119_4832_135	SARG|CAP74085	34.9	86	282	210	1.01e-09	56.2
ShaoY_2019_ERR3404634_bin.2_k119_4832_135	SARG|GQ205627.2.gene3.p01	48.1	52	282	216	2.70e-09	55.1
ShaoY_2019_ERR3404634_bin.2_k119_4832_135	SARG|AJ223604.1.gene5.p01	34.2	79	282	210	4.65e-09	54.3
ShaoY_2019_ERR3404634_bin.2_k119_4832_135	SARG|FJ460181.2.gene2.p01	35.4	79	282	210	6.32e-09	53.9
ShaoY_2019_ERR3404634_bin.2_k119_4832_135	SARG|AF418284.1.gene3.p01	35.4	79	282	210	6.32e-09	53.9
ShaoY_2019_ERR3404634_bin.2_k119_4832_135	SARG|AAS89471	35.4	79	282	210	6.32e-09	53.9
ShaoY_2019_ERR3404634_bin.2_k119_4832_135	SARG|AY123251.gene2.p01	35.4	79	282	210	6.32e-09	53.9
ShaoY_2019_ERR3404634_bin.2_k119_4832_135	NCBI|WP_010635894.1|1|1|catB8|catB8|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B-3_phenicol_O-acetyltransferase_CatB8|AMR|phenicol	35.4	79	282	210	6.32e-09	53.9
ShaoY_2019_ERR3404634_bin.2_k119_4869_8	SARG|gi|488374619|ref|WP_002444004.1|	19.7	259	281	452	2.16e-10	59.7
ShaoY_2019_ERR3404634_bin.2_k119_5091_7	SARG|gb|CTQ57092.1|ARO:3004682|aadA27	27.0	230	253	262	1.89e-15	72.8
ShaoY_2019_ERR3404634_bin.2_k119_5091_7	NCBI|WP_004758588.1|1|1|ant(3'')-IIc|ant(3'')-IIc|nucleotidyltransferase|2|SPECTINOMYCIN/STREPTOMYCIN|aminoglycoside|aminoglycoside_nucleotidyltransferase_ANT(3'')-IIc|AMR|aminoglycoside	26.1	230	253	262	2.39e-14	69.7
ShaoY_2019_ERR3404634_bin.2_k119_5091_7	SARG|gb|ENU37733|ARO:3004091|ANT(3'')-IIc	26.7	232	253	259	5.95e-14	68.6
ShaoY_2019_ERR3404634_bin.2_k119_5091_7	NCBI|WP_005001597.1|1|1|ant(3'')-IIc|ant(3'')-IIc|nucleotidyltransferase|2|SPECTINOMYCIN/STREPTOMYCIN|aminoglycoside|aminoglycoside_nucleotidyltransferase_ANT(3'')-IIc|AMR|aminoglycoside	25.9	232	253	262	8.42e-14	68.2
ShaoY_2019_ERR3404634_bin.2_k119_5091_9	SARG|ZP_04648601	100	384	385	384	2.72e-260	707
ShaoY_2019_ERR3404634_bin.2_k119_5091_9	SARG|ZP_03982909	100	384	385	394	3.95e-260	707
ShaoY_2019_ERR3404634_bin.2_k119_5091_9	SARG|AAY21388	99.7	384	385	384	1.57e-259	705
ShaoY_2019_ERR3404634_bin.2_k119_5091_9	SARG|ZP_03948381	99.5	384	385	394	9.29e-259	704
ShaoY_2019_ERR3404634_bin.2_k119_5091_9	SARG|gb|BAC11911.1|ARO:3003551|emeA	96.7	393	385	393	3.88e-253	689
ShaoY_2019_ERR3404634_bin.2_k119_5091_9	SARG|YP_808159	82.0	383	385	387	7.41e-215	592
ShaoY_2019_ERR3404634_bin.2_k119_5091_9	SARG|NP_390536	46.4	388	385	400	2.58e-111	330
ShaoY_2019_ERR3404634_bin.2_k119_5091_9	SARG|ZP_03592168	48.9	370	385	389	2.68e-108	322
ShaoY_2019_ERR3404634_bin.2_k119_5091_9	SARG|P33449	48.6	370	385	389	1.52e-107	320
ShaoY_2019_ERR3404634_bin.2_k119_5091_9	SARG|gi|656016562|ref|WP_029056449.1|	39.7	368	385	386	9.00e-92	280
ShaoY_2019_ERR3404634_bin.2_k119_5091_84	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	32.1	277	532	574	1.41e-38	147
ShaoY_2019_ERR3404634_bin.2_k119_5091_84	SARG|gb|AAC74000.1|ARO:3003950|msbA	28.7	282	532	582	8.56e-28	116
ShaoY_2019_ERR3404634_bin.2_k119_5091_84	SARG|gb|MBW0764195.1|ARO:3007027|salC	34.9	192	532	541	4.33e-18	86.3
ShaoY_2019_ERR3404634_bin.2_k119_5091_84	SARG|gb|MBW0770001.1|ARO:3007026|salB	30.9	223	532	541	2.19e-15	77.8
ShaoY_2019_ERR3404634_bin.2_k119_5091_84	SARG|gb|AGN74946|ARO:3003749|salA	31.4	188	532	541	3.67e-14	73.9
ShaoY_2019_ERR3404634_bin.2_k119_5091_84	SARG|gb|AVI44920.1|ARO:3004470|poxtA	28.3	187	532	542	6.63e-10	60.5
ShaoY_2019_ERR3404634_bin.2_k119_5091_84	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	28.3	187	532	544	6.65e-10	60.5
ShaoY_2019_ERR3404634_bin.2_k119_5091_84	SARG|gb|WP_082039181.1|ARO:3007028|salD	27.6	199	532	544	6.65e-10	60.5
ShaoY_2019_ERR3404634_bin.2_k119_5091_84	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	25.2	214	532	505	4.43e-09	57.8
ShaoY_2019_ERR3404634_bin.2_k119_5091_84	ResF|poxtA-Ef_1_WP094899500.1_1	26.2	206	532	538	4.30e-08	54.7
ShaoY_2019_ERR3404634_bin.2_k119_5091_102	SARG|gb|AAV85982.1|ARO:3000535|macB	40.7	221	244	644	1.34e-40	146
ShaoY_2019_ERR3404634_bin.2_k119_5091_102	SARG|gi|696368937|ref|WP_032943949.1|	36.4	228	244	648	3.58e-40	145
ShaoY_2019_ERR3404634_bin.2_k119_5091_102	SARG|gi|851913025|ref|WP_048215946.1|	36.6	227	244	648	4.92e-40	144
ShaoY_2019_ERR3404634_bin.2_k119_5091_102	SARG|gi|696361545|ref|WP_032936694.1|	36.4	228	244	648	4.92e-40	144
ShaoY_2019_ERR3404634_bin.2_k119_5091_102	SARG|gi|489930965|ref|WP_003834285.1|	36.6	227	244	648	4.92e-40	144
ShaoY_2019_ERR3404634_bin.2_k119_5091_102	SARG|gi|936194420|ref|WP_054528571.1|	36.6	227	244	648	6.77e-40	144
ShaoY_2019_ERR3404634_bin.2_k119_5091_102	SARG|gi|489936909|ref|WP_003840216.1|	36.6	227	244	648	6.77e-40	144
ShaoY_2019_ERR3404634_bin.2_k119_5091_102	SARG|gi|507079862|ref|WP_016150620.1|	36.6	227	244	648	6.77e-40	144
ShaoY_2019_ERR3404634_bin.2_k119_5091_102	SARG|gi|949791377|ref|WP_057104572.1|	36.6	227	244	648	6.77e-40	144
ShaoY_2019_ERR3404634_bin.2_k119_5091_102	SARG|YP_002850060	36.6	227	244	648	9.32e-40	144
ShaoY_2019_ERR3404634_bin.2_k119_5091_115	NCBI|WP_031281281.1|1|1|catB|catB|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B_phenicol_O-acetyltransferase|AMR|phenicol	41.7	60	234	210	6.10e-06	44.7
ShaoY_2019_ERR3404634_bin.2_k119_5091_168	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	47.0	230	235	228	3.74e-64	198
ShaoY_2019_ERR3404634_bin.2_k119_5091_168	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	44.5	227	235	232	1.11e-61	192
ShaoY_2019_ERR3404634_bin.2_k119_5091_168	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	44.5	227	235	232	1.11e-61	192
ShaoY_2019_ERR3404634_bin.2_k119_5091_168	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	45.7	223	235	232	1.26e-60	189
ShaoY_2019_ERR3404634_bin.2_k119_5091_168	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	45.3	223	235	231	2.46e-60	188
ShaoY_2019_ERR3404634_bin.2_k119_5091_168	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	42.7	227	235	233	7.41e-60	187
ShaoY_2019_ERR3404634_bin.2_k119_5091_168	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	41.6	231	235	239	9.23e-57	179
ShaoY_2019_ERR3404634_bin.2_k119_5091_168	NCBI|WP_063856727.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	42.2	232	235	232	2.12e-56	178
ShaoY_2019_ERR3404634_bin.2_k119_5091_168	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	39.4	231	235	235	2.32e-56	178
ShaoY_2019_ERR3404634_bin.2_k119_5091_168	NCBI|WP_016295750.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	42.2	232	235	232	3.00e-56	178
ShaoY_2019_ERR3404634_bin.2_k119_5091_169	CARD|gb|ABD30512.1|ARO:3000839|arlS	29.8	242	610	451	5.66e-35	136
ShaoY_2019_ERR3404634_bin.2_k119_5091_194	SARG|YP_002850060	31.4	226	347	648	4.11e-29	117
ShaoY_2019_ERR3404634_bin.2_k119_5091_194	SARG|gi|922960663|ref|WP_053388845.1|	31.1	219	347	648	4.11e-29	117
ShaoY_2019_ERR3404634_bin.2_k119_5091_194	SARG|gi|757799695|ref|WP_043016897.1|	31.1	219	347	648	5.57e-29	116
ShaoY_2019_ERR3404634_bin.2_k119_5091_194	SARG|gi|1045891604|ref|WP_065554100.1|	31.1	219	347	648	5.57e-29	116
ShaoY_2019_ERR3404634_bin.2_k119_5091_194	SARG|gi|507082903|ref|WP_016153652.1|	31.1	219	347	648	5.57e-29	116
ShaoY_2019_ERR3404634_bin.2_k119_5091_194	SARG|gi|696368937|ref|WP_032943949.1|	31.4	226	347	648	5.57e-29	116
ShaoY_2019_ERR3404634_bin.2_k119_5091_194	SARG|gi|851913025|ref|WP_048215946.1|	31.4	226	347	648	5.57e-29	116
ShaoY_2019_ERR3404634_bin.2_k119_5091_194	SARG|gi|740856590|ref|WP_038641842.1|	31.1	219	347	648	5.57e-29	116
ShaoY_2019_ERR3404634_bin.2_k119_5091_194	SARG|gi|507086196|ref|WP_016156937.1|	31.1	219	347	648	5.57e-29	116
ShaoY_2019_ERR3404634_bin.2_k119_5091_194	SARG|gi|489930965|ref|WP_003834285.1|	31.4	226	347	648	5.57e-29	116
ShaoY_2019_ERR3404634_bin.2_k119_5091_232	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	39.0	236	240	232	2.36e-48	158
ShaoY_2019_ERR3404634_bin.2_k119_5091_232	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	40.8	233	240	228	2.98e-48	157
ShaoY_2019_ERR3404634_bin.2_k119_5091_232	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.7	236	240	232	5.29e-47	154
ShaoY_2019_ERR3404634_bin.2_k119_5091_232	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.7	236	240	232	5.29e-47	154
ShaoY_2019_ERR3404634_bin.2_k119_5091_232	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	36.3	237	240	239	2.87e-45	150
ShaoY_2019_ERR3404634_bin.2_k119_5091_232	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	36.2	235	240	231	1.82e-44	148
ShaoY_2019_ERR3404634_bin.2_k119_5091_232	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	36.2	235	240	231	1.82e-44	148
ShaoY_2019_ERR3404634_bin.2_k119_5091_232	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	36.2	235	240	231	7.22e-44	146
ShaoY_2019_ERR3404634_bin.2_k119_5091_232	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	36.2	235	240	231	1.02e-43	146
ShaoY_2019_ERR3404634_bin.2_k119_5091_232	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	36.2	235	240	231	1.44e-43	145
ShaoY_2019_ERR3404634_bin.2_k119_5091_233	CARD|gb|ADM92606.1|ARO:3000549|adeS	25.9	297	490	361	4.16e-18	84.7
ShaoY_2019_ERR3404634_bin.2_k119_5091_233	megares|MEG_7514|Drugs|Glycopeptide|VanL-type_regulator|VANSL_1	27.1	273	490	364	8.11e-17	80.9
ShaoY_2019_ERR3404634_bin.2_k119_5091_233	NCBI|WP_063856745.1|1|1|vanS-L|vanS-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-L|AMR|glycopeptide	27.1	273	490	364	8.11e-17	80.9
ShaoY_2019_ERR3404634_bin.2_k119_5091_267	ResF|mre(A)_1_U92073_1	44.2	285	317	310	2.64e-73	227
ShaoY_2019_ERR3404634_bin.2_k119_5091_267	SARG|gb|AAB64408.1|ARO:3007050|mreA	44.2	285	317	311	2.72e-73	227
ShaoY_2019_ERR3404634_bin.2_k119_5091_291	SARG|gi|1035686596|ref|WP_064530178.1|	41.7	218	234	648	9.92e-49	168
ShaoY_2019_ERR3404634_bin.2_k119_5091_291	SARG|gi|974633183|ref|WP_059219858.1|	40.4	235	234	648	1.37e-48	167
ShaoY_2019_ERR3404634_bin.2_k119_5091_291	SARG|gi|974684692|ref|WP_059267998.1|	40.4	235	234	648	1.37e-48	167
ShaoY_2019_ERR3404634_bin.2_k119_5091_291	SARG|gi|974672242|ref|WP_059256507.1|	40.0	235	234	648	7.02e-48	166
ShaoY_2019_ERR3404634_bin.2_k119_5091_291	SARG|gi|974641719|ref|WP_059227752.1|	40.0	235	234	648	7.02e-48	166
ShaoY_2019_ERR3404634_bin.2_k119_5091_291	SARG|gi|643601187|ref|WP_025237288.1|	40.0	235	234	648	7.02e-48	166
ShaoY_2019_ERR3404634_bin.2_k119_5091_291	SARG|gi|974628291|ref|WP_059215695.1|	40.0	235	234	648	7.02e-48	166
ShaoY_2019_ERR3404634_bin.2_k119_5091_291	SARG|gi|446110298|ref|WP_000188153.1|	40.0	235	234	648	7.02e-48	166
ShaoY_2019_ERR3404634_bin.2_k119_5091_291	SARG|gi|446110299|ref|WP_000188154.1|	40.0	235	234	648	7.02e-48	166
ShaoY_2019_ERR3404634_bin.2_k119_5091_291	SARG|ZP_02903696	40.0	235	234	648	7.02e-48	166
ShaoY_2019_ERR3404634_bin.2_k119_5091_320	SARG|gi|657888313|ref|WP_029592374.1|	38.2	288	780	648	1.18e-47	178
ShaoY_2019_ERR3404634_bin.2_k119_5091_320	SARG|gi|746253210|ref|WP_039301529.1|	38.5	288	780	648	1.18e-47	178
ShaoY_2019_ERR3404634_bin.2_k119_5091_320	SARG|gi|746243059|ref|WP_039291473.1|	38.9	288	780	648	2.16e-47	177
ShaoY_2019_ERR3404634_bin.2_k119_5091_320	SARG|gi|1001720867|ref|WP_061274204.1|	38.2	288	780	648	2.16e-47	177
ShaoY_2019_ERR3404634_bin.2_k119_5091_320	SARG|gi|751930065|ref|WP_041144773.1|	37.8	288	780	648	2.93e-47	177
ShaoY_2019_ERR3404634_bin.2_k119_5091_320	SARG|gi|495736522|ref|WP_008461101.1|	38.2	288	780	648	3.97e-47	177
ShaoY_2019_ERR3404634_bin.2_k119_5091_320	SARG|gi|486403059|ref|WP_001607116.1|	38.4	289	780	648	3.97e-47	177
ShaoY_2019_ERR3404634_bin.2_k119_5091_320	SARG|gi|1035717981|ref|WP_064557480.1|	37.4	289	780	648	3.97e-47	177
ShaoY_2019_ERR3404634_bin.2_k119_5091_320	SARG|gi|757718708|ref|WP_042946953.1|	37.8	286	780	646	5.25e-47	176
ShaoY_2019_ERR3404634_bin.2_k119_5091_320	SARG|gi|852138723|ref|WP_048293411.1|	37.8	286	780	646	9.63e-47	176
ShaoY_2019_ERR3404634_bin.2_k119_5091_347	SARG|CP001581.1.gene725.p01	44.9	463	478	477	3.17e-140	410
ShaoY_2019_ERR3404634_bin.2_k119_5091_347	SARG|ZP_03053667	28.0	447	478	506	2.89e-53	186
ShaoY_2019_ERR3404634_bin.2_k119_5091_347	SARG|YP_001486998	27.7	448	478	530	3.27e-53	186
ShaoY_2019_ERR3404634_bin.2_k119_5091_347	SARG|CAB12101	27.0	460	478	512	1.68e-50	178
ShaoY_2019_ERR3404634_bin.2_k119_5091_347	NCBI|CAQ45064.1|1|1|emrB-sm|emrB-sm||1|EFFLUX|EFFLUX|multidrug_efflux_MFS_transporter_permease_subunit_EmrB|AMR|efflux	27.7	426	478	528	5.94e-50	177
ShaoY_2019_ERR3404634_bin.2_k119_5091_347	SARG|gi|745784185|ref|WP_039077609.1|	28.7	435	478	512	1.60e-47	170
ShaoY_2019_ERR3404634_bin.2_k119_5091_347	SARG|YP_001419960	27.6	450	478	510	2.15e-47	170
ShaoY_2019_ERR3404634_bin.2_k119_5091_347	SARG|gi|502671416|ref|WP_012907239.1|	29.0	435	478	512	4.26e-47	169
ShaoY_2019_ERR3404634_bin.2_k119_5091_347	SARG|gi|924625749|ref|WP_053529696.1|	28.6	430	478	512	1.13e-46	168
ShaoY_2019_ERR3404634_bin.2_k119_5091_347	SARG|gi|555267544|ref|WP_023248992.1|	28.6	430	478	512	1.13e-46	168
ShaoY_2019_ERR3404634_bin.2_k119_5091_376	SARG|gb|ADZ12699.1|ARO:3005091|RanA	29.4	197	335	258	7.52e-18	80.9
ShaoY_2019_ERR3404634_bin.2_k119_5091_384	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	34.4	299	300	293	2.83e-47	159
ShaoY_2019_ERR3404634_bin.2_k119_5091_384	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	29.9	308	300	307	2.36e-35	128
ShaoY_2019_ERR3404634_bin.2_k119_5091_384	SARG|gb|AAR96051.1|ARO:3002894|otrC	24.0	313	300	351	4.06e-21	90.9
ShaoY_2019_ERR3404634_bin.2_k119_5091_384	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	24.0	313	300	351	5.56e-21	90.5
ShaoY_2019_ERR3404634_bin.2_k119_5091_389	SARG|gb|QQA64075.1|ARO:3007043|msr(I)	42.5	482	499	485	2.77e-124	370
ShaoY_2019_ERR3404634_bin.2_k119_5091_389	SARG|gi|488231473|ref|WP_002302681.1|	44.4	484	499	492	1.55e-122	366
ShaoY_2019_ERR3404634_bin.2_k119_5091_389	SARG|AY004350.gene.p01	44.2	484	499	492	1.24e-121	364
ShaoY_2019_ERR3404634_bin.2_k119_5091_389	SARG|gi|488321355|ref|WP_002390740.1|	44.3	488	499	492	1.75e-121	363
ShaoY_2019_ERR3404634_bin.2_k119_5091_389	SARG|gi|488216250|ref|WP_002287458.1|	44.2	484	499	492	1.75e-121	363
ShaoY_2019_ERR3404634_bin.2_k119_5091_389	SARG|gi|488243106|ref|WP_002314314.1|	43.4	484	499	492	1.40e-120	361
ShaoY_2019_ERR3404634_bin.2_k119_5091_389	SARG|gi|488247627|ref|WP_002318835.1|	44.0	484	499	492	1.97e-120	361
ShaoY_2019_ERR3404634_bin.2_k119_5091_389	SARG|gb|QNR09092.1|ARO:3007042|msr(G)	40.7	482	499	485	1.01e-118	356
ShaoY_2019_ERR3404634_bin.2_k119_5091_389	SARG|DAC81085.1	39.6	482	499	486	5.16e-107	326
ShaoY_2019_ERR3404634_bin.2_k119_5091_389	SARG|QHW12308.1	38.6	484	499	486	1.96e-100	309
ShaoY_2019_ERR3404634_bin.2_k119_5091_443	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	28.5	319	297	346	1.78e-25	102
ShaoY_2019_ERR3404634_bin.2_k119_5091_480	SARG|gb|APB03219.1|ARO:3003986|TaeA	46.0	643	632	648	1.82e-183	533
ShaoY_2019_ERR3404634_bin.2_k119_5091_480	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	29.0	663	632	655	2.92e-70	239
ShaoY_2019_ERR3404634_bin.2_k119_5091_480	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	29.0	663	632	655	2.92e-70	239
ShaoY_2019_ERR3404634_bin.2_k119_5091_480	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	29.0	663	632	655	1.09e-69	237
ShaoY_2019_ERR3404634_bin.2_k119_5091_480	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.8	663	632	655	2.90e-69	236
ShaoY_2019_ERR3404634_bin.2_k119_5091_480	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.8	663	632	655	4.03e-69	236
ShaoY_2019_ERR3404634_bin.2_k119_5091_480	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.8	663	632	655	4.03e-69	236
ShaoY_2019_ERR3404634_bin.2_k119_5091_480	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.8	663	632	655	4.03e-69	236
ShaoY_2019_ERR3404634_bin.2_k119_5091_480	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.8	663	632	655	4.03e-69	236
ShaoY_2019_ERR3404634_bin.2_k119_5091_480	SARG|gb|AKA86814|ARO:3003746|optrA	28.8	663	632	655	4.03e-69	236
ShaoY_2019_ERR3404634_bin.2_k119_5091_482	SARG|gb|EOD99669.1|ARO:3002875|dfrE	98.8	164	165	164	2.69e-123	342
ShaoY_2019_ERR3404634_bin.2_k119_5091_482	NCBI|WP_290468344.1|1|1|dfrL|dfrL|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrL|AMR|diaminopyrimidine	45.7	162	165	176	1.17e-45	146
ShaoY_2019_ERR3404634_bin.2_k119_5091_482	CARD|gb|CAC8536249.1|ARO:3007456|dfrL	45.7	162	165	193	1.93e-45	146
ShaoY_2019_ERR3404634_bin.2_k119_5091_482	SARG|gb|CBL80435.1|ARO:3002869|dfrK	35.6	160	165	163	2.33e-37	125
ShaoY_2019_ERR3404634_bin.2_k119_5091_482	NCBI|WP_031775848.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	35.6	160	165	163	2.33e-37	125
ShaoY_2019_ERR3404634_bin.2_k119_5091_482	NCBI|WP_012779617.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	35.0	160	165	163	3.76e-36	122
ShaoY_2019_ERR3404634_bin.2_k119_5091_482	SARG|gb|AAA25550.1|ARO:3003105|dfrA3	39.8	161	165	162	1.47e-35	120
ShaoY_2019_ERR3404634_bin.2_k119_5091_482	SARG|gb|BAE15963.1|ARO:3002868|dfrG	35.0	160	165	165	2.26e-35	120
ShaoY_2019_ERR3404634_bin.2_k119_5091_482	SARG|CAL48457	36.1	166	165	183	7.46e-35	119
ShaoY_2019_ERR3404634_bin.2_k119_5091_482	SARG|gb|AAA85213.1|ARO:3002866|dfrD	33.8	160	165	162	3.78e-33	114
ShaoY_2019_ERR3404634_bin.2_k119_5091_496	SARG|gb|WP_104671188.1|ARO:3003948|efrA	30.7	574	583	575	3.12e-82	267
ShaoY_2019_ERR3404634_bin.2_k119_5091_496	SARG|gb|AAK76136.1|ARO:3000025|patB	31.0	588	583	588	3.21e-81	265
ShaoY_2019_ERR3404634_bin.2_k119_5091_496	SARG|gi|928900436|ref|WP_053931243.1|	29.8	577	583	600	4.67e-79	259
ShaoY_2019_ERR3404634_bin.2_k119_5091_496	SARG|gi|664579989|ref|WP_031094015.1|	29.8	577	583	601	4.78e-79	259
ShaoY_2019_ERR3404634_bin.2_k119_5091_496	SARG|gi|695842130|ref|WP_032755430.1|	30.8	549	583	603	1.37e-78	258
ShaoY_2019_ERR3404634_bin.2_k119_5091_496	SARG|gi|926400371|ref|WP_053728483.1|	29.2	578	583	603	1.37e-78	258
ShaoY_2019_ERR3404634_bin.2_k119_5091_496	SARG|gi|648667297|ref|WP_026359044.1|	29.3	577	583	605	7.63e-78	256
ShaoY_2019_ERR3404634_bin.2_k119_5091_496	SARG|gi|1033217078|gb|OAR27197.1|	29.7	580	583	601	9.74e-78	256
ShaoY_2019_ERR3404634_bin.2_k119_5091_496	SARG|gi|944009777|ref|WP_055601444.1|	30.8	549	583	628	1.78e-77	256
ShaoY_2019_ERR3404634_bin.2_k119_5091_496	SARG|gi|948137056|ref|WP_056795395.1|	30.0	577	583	602	1.95e-77	255
ShaoY_2019_ERR3404634_bin.2_k119_5091_497	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	36.8	573	593	579	1.96e-103	323
ShaoY_2019_ERR3404634_bin.2_k119_5091_497	SARG|gb|AAK76136.1|ARO:3000025|patB	35.1	584	593	588	7.58e-102	319
ShaoY_2019_ERR3404634_bin.2_k119_5091_497	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	35.7	580	593	579	1.17e-101	318
ShaoY_2019_ERR3404634_bin.2_k119_5091_497	SARG|gi|1033217078|gb|OAR27197.1|	34.1	575	593	601	8.98e-100	314
ShaoY_2019_ERR3404634_bin.2_k119_5091_497	SARG|gi|928900436|ref|WP_053931243.1|	33.6	575	593	600	6.73e-99	312
ShaoY_2019_ERR3404634_bin.2_k119_5091_497	SARG|gi|664579989|ref|WP_031094015.1|	33.6	575	593	601	6.91e-99	312
ShaoY_2019_ERR3404634_bin.2_k119_5091_497	SARG|gi|944152509|ref|WP_055644808.1|	32.5	567	593	616	2.83e-98	311
ShaoY_2019_ERR3404634_bin.2_k119_5091_497	SARG|gi|516795764|ref|WP_018105258.1|	33.5	559	593	601	3.78e-98	310
ShaoY_2019_ERR3404634_bin.2_k119_5091_497	SARG|gi|639892676|ref|WP_024755698.1|	32.6	567	593	631	8.20e-98	310
ShaoY_2019_ERR3404634_bin.2_k119_5091_497	SARG|gi|947982677|ref|WP_056642336.1|	32.5	567	593	626	2.00e-97	309
ShaoY_2019_ERR3404634_bin.2_k119_5091_521	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	40.7	675	686	703	1.38e-144	437
ShaoY_2019_ERR3404634_bin.2_k119_5091_537	CARD|gb|BAB36671.1|ARO:3000832|evgA	26.1	111	194	204	8.34e-11	57.8
ShaoY_2019_ERR3404634_bin.2_k119_5091_537	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	27.6	127	194	228	2.57e-09	53.9
ShaoY_2019_ERR3404634_bin.2_k119_5091_542	SARG|gb|ABX00624.1|ARO:3002881|lmrC	30.1	193	256	550	2.77e-15	73.9
ShaoY_2019_ERR3404634_bin.2_k119_5091_542	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	25.1	219	256	574	6.94e-15	72.8
ShaoY_2019_ERR3404634_bin.2_k119_5091_542	SARG|FR772051.1.gene9.p01	29.5	217	256	524	1.21e-14	72.0
ShaoY_2019_ERR3404634_bin.2_k119_5091_542	SARG|gb|AHB37625.1|ARO:3004715|vga(E)	27.1	225	256	524	3.25e-13	67.8
ShaoY_2019_ERR3404634_bin.2_k119_5091_542	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	25.1	239	256	505	7.82e-13	66.6
ShaoY_2019_ERR3404634_bin.2_k119_5091_542	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	215	256	655	3.85e-12	64.7
ShaoY_2019_ERR3404634_bin.2_k119_5091_542	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	215	256	655	3.85e-12	64.7
ShaoY_2019_ERR3404634_bin.2_k119_5091_542	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	27.9	215	256	655	1.70e-11	62.8
ShaoY_2019_ERR3404634_bin.2_k119_5091_542	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	23.8	239	256	504	2.77e-11	62.0
ShaoY_2019_ERR3404634_bin.2_k119_5091_542	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	27.9	215	256	655	4.13e-11	61.6
ShaoY_2019_ERR3404634_bin.2_k119_5091_550	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	34.0	212	300	346	1.86e-20	89.0
ShaoY_2019_ERR3404634_bin.2_k119_5091_574	SARG|gi|446048013|ref|WP_000125868.1|	38.3	133	428	648	1.35e-13	71.6
ShaoY_2019_ERR3404634_bin.2_k119_5091_574	SARG|gi|835330218|ref|WP_047457825.1|	37.6	133	428	648	1.80e-13	71.2
ShaoY_2019_ERR3404634_bin.2_k119_5091_574	SARG|YP_001453760	37.6	133	428	648	1.80e-13	71.2
ShaoY_2019_ERR3404634_bin.2_k119_5091_574	SARG|gi|502669352|ref|WP_012905216.1|	37.6	133	428	648	2.38e-13	70.9
ShaoY_2019_ERR3404634_bin.2_k119_5091_574	SARG|gi|554685678|ref|WP_023185565.1|	36.8	133	428	648	4.20e-13	70.1
ShaoY_2019_ERR3404634_bin.2_k119_5091_574	SARG|gi|976150171|ref|WP_059308384.1|	37.6	133	428	646	7.38e-13	69.3
ShaoY_2019_ERR3404634_bin.2_k119_5091_574	SARG|gi|1017024088|ref|WP_063159864.1|	37.3	134	428	646	7.38e-13	69.3
ShaoY_2019_ERR3404634_bin.2_k119_5091_574	SARG|gi|969848384|ref|WP_058609247.1|	37.6	133	428	646	7.38e-13	69.3
ShaoY_2019_ERR3404634_bin.2_k119_5091_574	SARG|gi|782700886|ref|WP_045611431.1|	36.1	133	428	646	7.38e-13	69.3
ShaoY_2019_ERR3404634_bin.2_k119_5091_574	SARG|gi|1022641085|ref|WP_063404331.1|	37.6	133	428	646	7.38e-13	69.3
ShaoY_2019_ERR3404634_bin.2_k119_5091_575	SARG|gi|506220920|ref|WP_015740695.1|	45.7	221	227	647	1.45e-57	191
ShaoY_2019_ERR3404634_bin.2_k119_5091_575	SARG|gi|757782629|ref|WP_043001213.1|	44.8	221	227	648	5.54e-57	190
ShaoY_2019_ERR3404634_bin.2_k119_5091_575	SARG|gi|992390012|ref|WP_061077002.1|	44.8	221	227	648	5.54e-57	190
ShaoY_2019_ERR3404634_bin.2_k119_5091_575	SARG|gi|763407609|ref|WP_044264203.1|	44.8	221	227	648	5.54e-57	190
ShaoY_2019_ERR3404634_bin.2_k119_5091_575	SARG|gi|835330218|ref|WP_047457825.1|	44.8	221	227	648	7.72e-57	189
ShaoY_2019_ERR3404634_bin.2_k119_5091_575	SARG|YP_001453760	44.8	221	227	648	7.72e-57	189
ShaoY_2019_ERR3404634_bin.2_k119_5091_575	SARG|gi|556495988|ref|WP_023343675.1|	45.0	222	227	646	1.46e-56	189
ShaoY_2019_ERR3404634_bin.2_k119_5091_575	SARG|gi|968563772|ref|WP_058587854.1|	44.3	221	227	648	1.50e-56	189
ShaoY_2019_ERR3404634_bin.2_k119_5091_575	SARG|gi|835233765|ref|WP_047410073.1|	45.2	221	227	648	1.50e-56	189
ShaoY_2019_ERR3404634_bin.2_k119_5091_575	SARG|gi|754951242|ref|WP_042307417.1|	45.2	221	227	648	1.50e-56	189
ShaoY_2019_ERR3404634_bin.2_k119_5091_599	CARD|gb|AAL19308.1|ARO:3000504|golS	46.2	65	252	154	6.17e-10	55.5
ShaoY_2019_ERR3404634_bin.2_k119_5091_603	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	38.6	233	237	228	1.10e-58	184
ShaoY_2019_ERR3404634_bin.2_k119_5091_603	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	38.2	233	237	229	1.47e-56	179
ShaoY_2019_ERR3404634_bin.2_k119_5091_603	CARD|gb|ATC67679.1|ARO:3000838|arlR	40.0	230	237	219	4.35e-56	177
ShaoY_2019_ERR3404634_bin.2_k119_5091_603	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	39.9	233	237	230	1.95e-54	173
ShaoY_2019_ERR3404634_bin.2_k119_5091_603	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	38.8	232	237	231	1.45e-51	166
ShaoY_2019_ERR3404634_bin.2_k119_5091_603	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	37.4	227	237	231	1.45e-51	166
ShaoY_2019_ERR3404634_bin.2_k119_5091_603	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.8	232	237	231	1.45e-51	166
ShaoY_2019_ERR3404634_bin.2_k119_5091_603	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	38.6	228	237	232	1.69e-50	163
ShaoY_2019_ERR3404634_bin.2_k119_5091_603	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	38.4	229	237	231	2.32e-50	163
ShaoY_2019_ERR3404634_bin.2_k119_5091_603	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	36.6	232	237	232	2.39e-50	163
ShaoY_2019_ERR3404634_bin.2_k119_5091_604	CARD|gb|ABD30512.1|ARO:3000839|arlS	32.8	268	592	451	2.60e-35	137
ShaoY_2019_ERR3404634_bin.2_k119_5091_604	NCBI|WP_063856744.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	32.5	231	592	381	3.48e-28	115
ShaoY_2019_ERR3404634_bin.2_k119_5091_604	megares|MEG_7504|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	32.5	231	592	381	3.48e-28	115
ShaoY_2019_ERR3404634_bin.2_k119_5091_604	megares|MEG_7507|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	30.7	231	592	381	1.17e-27	114
ShaoY_2019_ERR3404634_bin.2_k119_5091_604	NCBI|WP_063856738.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	30.7	231	592	381	1.17e-27	114
ShaoY_2019_ERR3404634_bin.2_k119_5091_604	NCBI|WP_011461302.1|1|1|vanS-I|vanS-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-I|AMR|glycopeptide	30.7	231	592	392	2.51e-27	113
ShaoY_2019_ERR3404634_bin.2_k119_5091_604	NCBI|WP_023042297.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	30.7	231	592	381	2.90e-27	112
ShaoY_2019_ERR3404634_bin.2_k119_5091_604	megares|MEG_7509|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	30.7	231	592	381	2.90e-27	112
ShaoY_2019_ERR3404634_bin.2_k119_5091_604	megares|MEG_7486|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	33.0	227	592	382	2.95e-27	112
ShaoY_2019_ERR3404634_bin.2_k119_5091_604	NCBI|WP_063856731.1|1|1|vanS-A|vanS-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-A|AMR|glycopeptide	33.0	227	592	382	2.95e-27	112
ShaoY_2019_ERR3404634_bin.2_k119_5213_21	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	33.4	308	394	365	4.20e-50	171
ShaoY_2019_ERR3404634_bin.2_k119_5213_21	megares|MEG_7486|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	35.8	254	394	382	3.37e-49	169
ShaoY_2019_ERR3404634_bin.2_k119_5213_21	NCBI|WP_063856731.1|1|1|vanS-A|vanS-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-A|AMR|glycopeptide	35.8	254	394	382	3.37e-49	169
ShaoY_2019_ERR3404634_bin.2_k119_5213_21	megares|MEG_7487|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	35.4	254	394	386	5.16e-49	169
ShaoY_2019_ERR3404634_bin.2_k119_5213_21	NCBI|WP_063856740.1|1|1|vanS-Pt2|vanS-Pt2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt2|AMR|glycopeptide	35.4	254	394	386	5.16e-49	169
ShaoY_2019_ERR3404634_bin.2_k119_5213_21	NCBI|WP_002305818.1|1|1|vanS-A|vanS-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-A|AMR|glycopeptide	35.4	254	394	384	1.89e-48	167
ShaoY_2019_ERR3404634_bin.2_k119_5213_21	megares|MEG_7454|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	35.4	254	394	384	1.89e-48	167
ShaoY_2019_ERR3404634_bin.2_k119_5213_21	NCBI|WP_063856742.1|1|1|vanS-Pt|vanS-Pt|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt|AMR|glycopeptide	35.0	254	394	388	4.04e-48	167
ShaoY_2019_ERR3404634_bin.2_k119_5213_21	megares|MEG_7489|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	35.0	254	394	388	4.04e-48	167
ShaoY_2019_ERR3404634_bin.2_k119_5213_21	NCBI|WP_063856741.1|1|1|vanS-Pt|vanS-Pt|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt|AMR|glycopeptide	34.6	254	394	386	2.06e-47	165
ShaoY_2019_ERR3404634_bin.2_k119_5213_22	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	51.1	227	230	231	1.63e-72	219
ShaoY_2019_ERR3404634_bin.2_k119_5213_22	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	49.6	228	230	232	3.15e-70	213
ShaoY_2019_ERR3404634_bin.2_k119_5213_22	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	47.0	230	230	233	7.50e-69	210
ShaoY_2019_ERR3404634_bin.2_k119_5213_22	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	45.9	233	230	235	1.48e-66	204
ShaoY_2019_ERR3404634_bin.2_k119_5213_22	NCBI|WP_063856722.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	46.3	231	230	232	2.19e-65	201
ShaoY_2019_ERR3404634_bin.2_k119_5213_22	NCBI|WP_023042613.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	47.6	231	230	232	6.23e-65	200
ShaoY_2019_ERR3404634_bin.2_k119_5213_22	NCBI|WP_016295750.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	47.6	231	230	232	6.23e-65	200
ShaoY_2019_ERR3404634_bin.2_k119_5213_22	NCBI|WP_023043165.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	46.8	231	230	232	1.25e-64	199
ShaoY_2019_ERR3404634_bin.2_k119_5213_22	NCBI|WP_063856727.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	47.2	231	230	232	1.77e-64	199
ShaoY_2019_ERR3404634_bin.2_k119_5213_22	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	46.1	228	230	229	3.24e-64	198
